NO831680L - PYROGALL-DERIVATIVES. - Google Patents

PYROGALL-DERIVATIVES.

Info

Publication number
NO831680L
NO831680L NO831680A NO831680A NO831680L NO 831680 L NO831680 L NO 831680L NO 831680 A NO831680 A NO 831680A NO 831680 A NO831680 A NO 831680A NO 831680 L NO831680 L NO 831680L
Authority
NO
Norway
Prior art keywords
hydrogen
general formula
solution
benzodioxole
dimethyl
Prior art date
Application number
NO831680A
Other languages
Norwegian (no)
Inventor
Ludwig H Schlager
Original Assignee
Gerot Pharmazeutika
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AT188882A external-priority patent/AT375654B/en
Priority claimed from AT467182A external-priority patent/AT375360B/en
Priority claimed from AT129883A external-priority patent/AT378191B/en
Application filed by Gerot Pharmazeutika filed Critical Gerot Pharmazeutika
Publication of NO831680L publication Critical patent/NO831680L/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/02Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
    • A01N43/24Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with two or more hetero atoms
    • A01N43/26Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with two or more hetero atoms five-membered rings
    • A01N43/28Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with two or more hetero atoms five-membered rings with two hetero atoms in positions 1,3
    • A01N43/30Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with two or more hetero atoms five-membered rings with two hetero atoms in positions 1,3 with two oxygen atoms in positions 1,3, condensed with a carbocyclic ring
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/34Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
    • A01N43/36Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom five-membered rings
    • A01N43/38Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom five-membered rings condensed with carbocyclic rings
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/34Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
    • A01N43/40Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/501,3-Diazoles; Hydrogenated 1,3-diazoles
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/541,3-Diazines; Hydrogenated 1,3-diazines
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/601,4-Diazines; Hydrogenated 1,4-diazines
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/84Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms six-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/64Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03FPHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
    • G03F7/00Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printing surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
    • G03F7/004Photosensitive materials
    • G03F7/027Non-macromolecular photopolymerisable compounds having carbon-to-carbon double bonds, e.g. ethylenic compounds
    • G03F7/028Non-macromolecular photopolymerisable compounds having carbon-to-carbon double bonds, e.g. ethylenic compounds with photosensitivity-increasing substances, e.g. photoinitiators
    • G03F7/031Organic compounds not covered by group G03F7/029

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Dentistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • General Physics & Mathematics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Description

IIN

foreliggende oppfinnelse vedrører nye kjernesubstituerte pyrogallolderivater med den generelle formel the present invention relates to new core-substituted pyrogallol derivatives with the general formula

I hvor R ogR2kan være like eller forskjellige og betyr I hydrogen eller lavere alkyl og R I where R and R2 can be the same or different and means I hydrogen or lower alkyl and R

i in

j j

j (|i) hydrogen ellerj (|i) hydrogen or

(jii) (yikes)

idetI whileI

I IN

(ji) når R betyr hydrogen, betyr X, Y og Z hydrogen, halogen, eller nitro, med det forbehold at ikke alle tre sam-: tidig er hydrogen, og med det ytterligere forbehold at (ji) when R is hydrogen, X, Y and Z are hydrogen, halogen, or nitro, with the proviso that not all three are simultaneously hydrogen, and with the further proviso that

når R^, R2, X og Z betyr hydrogen, kan Y ikke være noen N02-gruppe; j when R 1 , R 2 , X and Z are hydrogen, Y cannot be any NO 2 group; j

I og In and

(jii) a) når R betyr gruppen (jii) a) when R means the group

er R^og R^like eller forskjellige og betyr hydrogen eller lavere | alkvl, X, Y og Z er likeledes like eller forskjellige og betyr hydrogen, halogen eller nitro, n er null, j 1 eller 2, R,- hydrogen, oksiranyl, mono- eller dji-i hydroksyalkyl, N- (dihydroksyalkyl) -amino-hydroks.y-alkyl, karboksy, karbalkoksy, karbamyl, N-alkylki ar-i akbmaamridyboalmk, ysNilmg,Nr, u-odppkiaesnlimks yeaslmktaeir nrrbaeemlsylt elr o, gdcsyå iaanklka, yn .A lva2 æc-erime taidelan , zmoideletintte-!t2-yl, heterocyklisk ring med tilsammen to heterogenatomer;<1>eller i b) X er hydrogen eller allyl, Y, Z, R^ og R^er hydrogen og n er null, R^betyr gruppen are R^ and R^ the same or different and mean hydrogen or lower | alkvl, X, Y and Z are likewise the same or different and mean hydrogen, halogen or nitro, n is zero, j 1 or 2, R,- hydrogen, oxiranyl, mono- or dji-i hydroxyalkyl, N-(dihydroxyalkyl) - amino-hydroxy.y-alkyl, carboxy, carbaloxy, carbamyl, N-alkylki ar-i akbmaamridyboalmk, ysNilmg,Nr, u-odppkiaesnlimks yeaslmktaeir nrrbaeemlsylt elr o, gdcsyå iaanklka, yn .A lva2 æc-erime taidelan , zmoideletintte-!t2 -yl, heterocyclic ring with a total of two heteroatoms;<1>or in b) X is hydrogen or allyl, Y, Z, R^ and R^ are hydrogen and n is zero, R^ denotes the group

hvori Rg kan være hydrogen eller lavere wherein Rg may be hydrogen or lower

alkyl eller sammen med R^danner en fem- eller seksledde<j>t mettet heterocyklisk ring, som inneholdermaksimalt to he,tero- alkyl or together with R^ forms a five- or six-membered<j>t saturated heterocyclic ring, containing a maximum of two he, hetero-

genatomer, R^ betyr alkyl, alkenyl, alkinyl, alkoksyalkyjl, gene atoms, R^ means alkyl, alkenyl, alkynyl, alkoxyalkyl,

cykloalkyl, dialky lamino-lkyl, aryl, aralkyl, heteroalkyjl, karbamoylalkyl eller en fem- eller seksleddet og likeledes kondensert heterocyklisk rest med maksimalt tre heterogejn- cycloalkyl, dialkylaminoalkyl, aryl, aralkyl, heteroalkyl, carbamoylalkyl or a five- or six-membered and likewise condensed heterocyclic radical with a maximum of three heterogen-

aitomer; atoms;

samt deres salter med uorganiske eller organiske syrer eller as well as their salts with inorganic or organic acids or

! baser. ! bases.

i in

I Videre vedrører oppfinnelsen en fremgangsmåte til fremstilling In addition, the invention relates to a method for production

derav. hence.

i in

i I De nye forbindelser kan ifølge oppfinnelsen fremstilles j som følger: According to the invention, the new compounds can be prepared as follows:

I IN

i in

a) Forbindelser med formel a) Compounds with formula

^yCX., ^yCX.,

hvori R^, R2, X, Y og Z har den under (i) angitte betydn'ing wherein R 1 , R 2 , X, Y and Z have the meaning given under (i).

fremstilles ved at man behandler et 4^-hydroksy-l, 3-benzodiok- is produced by treating a 4^-hydroxy-1, 3-benzodioc-

sol med den generelle formel sol with the general formula

h; vori R, og R0har ovenfor nevnte betydning, fortrinnsviisi et inert løsningsmiddel eller løsningsmiddelblanding ii en en- eller totrinnsreaksjon, eventuelt under_anvendelse h; where R, and R0 have the meaning mentioned above, preferably an inert solvent or solvent mixture in a one- or two-step reaction, possibly during_use

'av syrebindende tilsetninger og/eller katalysatorer, med halogenerings- og/eller nitreringsmidler. of acid-binding additives and/or catalysts, with halogenating and/or nitrating agents.

i in

; i ; in

ib) Pyrogalloleter med den generelle formel ib) Pyrogallol ethers of the general formula

:hyor X, R^, R,,, Rg og R^ har den under (ii) b) angitte betydning, samt deres salter og optisk aktive isomere fremstilles ved at man omsetter en 4-hydroksy-l,3-benzodioksdl méd den generelle formel hvor R^, R2og X har den ovenfor nevnte betydning, eller j ' et alkalisalt derav med et epihalogenhydrin, behandler det derved fremstilte produkt med den generelle formel :hyor X, R^, R,,, Rg and R^ has the meaning given under (ii) b), as well as their salts and optically active isomers are prepared by reacting a 4-hydroxy-1,3-benzodioxdl with the general formula where R 1 , R 2 and X have the above-mentioned meaning, or j ' an alkali salt thereof with an epihalohydrin, treat the thereby produced product with the general formula

— v — v

hvori Rg betyr -CHOH.CH2Qeller wherein Rg means -CHOH.CH2Qor

i i idet Q er et halogenatom,med et amin med den generelle formel<1>i i i where Q is a halogen atom, with an amine of the general formula <1>i

(hvori Rg og R^har den ovenfor angitte betydning, og om jønsket spalte det derved erholdte derivat med den generelle (in which Rg and R^ have the meaning given above, and if desired, split the thereby obtained derivative with the general

formel (Ib) i de optiske antipoder og/eller eventuelt formula (Ib) in the optical antipodes and/or optionally

i in

overfører det i et salt med en fysiologisk fordragelig syre transfers it in a salt with a physiologically tolerable acid

ieller base. or base.

I I I I

1 1

c) i Derivater av pyrogalloletere med den generelle formel i c) i Derivatives of pyrogallole ethers of the general formula i

jhyori R^, R,,, R-^, R^, R^, X, Y, Z og n har den under (iij a)<:>angitte betydning, fremstilles ved at man omsetter et pyro-I! g_aillolderivat med den generelle formel Ihyor R^,R2, X, Y og Z har den ovenfor nevnte betydning,] .eller et fenolat herav, fortrinnsvis et inert løsningsmiddel!i jel; ler løsningsmiddelblandinger, med en forbindelse med deI n<!>j ! ge!nerelle formel jhyori R^, R,,, R-^, R^, R^, X, Y, Z and n has the meaning given under (iij a)<:>, is produced by reacting a pyro-I! g_aillol derivative with the general formula Ihyor R1, R2, X, Y and Z have the above-mentioned meaning,] .or a phenolate thereof, preferably an inert solvent!in gel; ler solvent mixtures, with a compound with deI n<!>j ! general formula

i hvori R^, R^og n har ovenfor nevnte betydning, R,-1 har samme betydning som R,, eller betyr en CH.CN-gruppe og A betyr i jhalogen, en sulfonyloksyrest eller i det tilfelle at R^ og R^<;>er hydrogen, n = null og R,.' er en CH.CN-gruppe, betyr eri dobbeltbinding med det nabostående karbonatom, eventuelt I i! et.erholdt derivat med.den generelle formel ..(Ic) overfarer in which R^, R^ and n have the above meaning, R,-1 has the same meaning as R,, or means a CH.CN group and A means in jhalogen, a sulfonyloxy acid residue or in the case that R^ and R ^<;>is hydrogen, n = zero and R,.' is a CH.CN group, eri means a double bond with the neighboring carbon atom, possibly I i! an.obtained derivative with.the general formula ..(Ic) exceeds

eh I gruppe R<. i en annen gruppe R_ og i det tilfellet at X , og1/ eh In group R<. in another group R_ and in the case that X , and1/

eller Y og/eller Z betyr hydrogen, behandler den erholdte or Y and/or Z means hydrogen, treats the obtained

forbindelse med den generelle formel (Ic) om ønsket med halogenerings- og/eller nitreringsmidler. compound with the general formula (Ic) if desired with halogenating and/or nitrating agents.

I IN

No<i>en av de nye forbindelser ifølge oppfinnelsen, spesiell No<i>en of the new compounds according to the invention, special

med formel (Ia) og (Ic) er på den ene side verdifulle råstoffer for fremstilling av jordbrukskjemikalier eller er slike i seg selv, på den annen side kan de - etter hydrolytisk oppspalting av dioksolanringen - tjene til å fremstille ellers vanskelig tilgjengelig kjernesubstituerte with formula (Ia) and (Ic) are, on the one hand, valuable raw materials for the production of agricultural chemicals or are such in themselves, on the other hand - after hydrolytic cleavage of the dioxolane ring - they can be used to produce otherwise difficult-to-access core-substituted

pyirogallolderivater. pyirogallol derivatives.

I IN

De kan anvendes for fremstilling av legemidler, røntgenkon-tirastmidler og f otosensibilisatorer . They can be used for the production of medicines, X-ray contrast agents and photosensitizers.

; j De nye forbindelser med formel (Ib) foreligger med fordel ; j The new compounds of formula (Ib) are available with advantage

i] form av deres salter med ionebyttere. in] form of their salts with ion exchangers.

i in

Disse nye pyrogalloletere med formel (Ib) samt deres salter og optisk aktive isomere kan anvendes som/S-blokkerende og analgetiske legemidler. Foretrukket er anvendelsen av slike These new pyrogallole ethers of formula (Ib) as well as their salts and optically active isomers can be used as /S-blocking and analgesic drugs. The use of such is preferred

legemidler i form av salter med ionebyttere. medicines in the form of salts with ion exchangers.

Under uttrykket "lavere alkyl" forstås spesielt metyl, et1<y>l,<!>propyl, butyl, pentyl, heksyl, heptyl og oktyl samt forgrenede rester såsom isopropyl, tert.butyl og 2,2-dimetylpropyl.j i<!>! i Under the term "lower alkyl" is meant especially methyl, et1<y>l,<!>propyl, butyl, pentyl, hexyl, heptyl and octyl as well as branched residues such as isopropyl, tert.butyl and 2,2-dimethylpropyl.j i<!> ! in

Som heterogenatomer for ringdannelsen med As heteroatoms for the ring formation with

I IN

kommeri l I comer l I

I IN

[okisygen, nitrogen eller svovel i betraktning. [oxygen, nitrogen or sulfur in consideration.

Sloim ge sasylrtdear nnsåensodm e kfo.mepkosn. eNn-tceyr kkloahn ekensyteln suflyfasmioinlosgyriesk , s<fo>a<r>l<d>t<r>s<a>y<I>r<g>e<e->Sloim ge sasylrtdear nnsåensodm e kfo.mepkosn. eNn-tceyr kkloahn ekensyteln suflyfasmioinlosgyrian , s<fo>a<r>l<d>t<r>s<a>y<I>r<g>e<e->

iO.I. anvendes eller også optisk aktive syrer, som muliggjør j i i en . racematspaltning såsom ( +) -kamf er-10-sulf onsyre { f>) , dii-tbenzoyl-D-vinsyre og andre men også sure kationbyttere méd fortrinnsvis makroporøs struktur, som danner resinater med dferivatene med den generelle formel (I), fra hvilke virke- iO.I. are used or also optically active acids, which enable j i i en . racemate cleavage such as (+)-camphor-10-sulfonic acid {f>), di-tbenzoyl-D-tartaric acid and other but also acidic cation exchangers with preferably macroporous structure, which form resinates with the derivatives of the general formula (I), from which works

[ [

.s.., toffet frigjøres retardert etter applikasjonen. Når restIenR',, inneholder en sur gruppe (såsom f.eks. -COOH) , kan også .s.., the toffet is released retardedly after application. When the residue R',, contains an acidic group (such as, for example -COOH), can also

en uorganisk eller organisk base tjene som saltdannende an inorganic or organic base serve as a salt former

bestanddel såsom f.eks. natriumhydroksyd, dimetylaminoetanol, component such as e.g. sodium hydroxide, dimethylaminoethanol,

NjI-mety 1-glukamin og lignende. NjI-methyl 1-glucamine and the like.

Naturlig forekommende og syntetiske pyrogalloletere og de<i>res derivater har forskjellige farmakologiske virkninger (Airzneim.-Forsch. 13, 226 (1963)). Dette gjelder ogsa slike foirbindelser hovr to orto-oksygenatomer er bundet sammen til en 1,3-benzodioksolring såsom f.eks. ved at apiol eller Naturally occurring and synthetic pyrogallole ethers and their derivatives have different pharmacological actions (Airzneim.-Forsch. 13, 226 (1963)). This also applies to such bonds where two ortho-oxygen atoms are bound together to form a 1,3-benzodioxole ring, such as e.g. by that apiol or

myi risticin som forekommer i krydderoljer, hvorav førstnevi ntei virker antipyretisk og fremkaller veer, mens sistnevnte gis myristicin that occurs in spice oils, the first nine of which are antipyretic and induce labor, while the latter is given

en psykotrop virkning. En pyrogalloleter som inneholder I a psychotropic effect. A pyrogallol ether containing I

nitrogen i eterresten, "Gallamin" er en ganglienblokker bg nitrogen in the ether residue, "Gallamine" is a ganglion blocker bg

muskelrelaksant. muscle relaxant.

I IN

Basiske pyrogalloletere med den generelle formel (Ib) er i m1ed unntak av et mellomprodukt (C. Casagrande et al., Boll. Chim.Farm. 112, 445 (1973)) er hittil ikke kjent. De nye[Pyrogalloletere ifølge oppfinnelsen viser seg å være/S-adrenozeptorblokkerende forbindelser som til forskjell fira kjente/S-blokkerende fenoksyisopropanolamin-derivater over-<i>jraiskendeogså virker sterkt anagetisk. Basic pyrogallole ethers of the general formula (Ib) are, with the exception of an intermediate (C. Casagrande et al., Boll. Chim. Pharm. 112, 445 (1973)) hitherto unknown. The new Pyrogallol ethers according to the invention turn out to be S-adrenoceptor-blocking compounds which, in contrast to the known S-blocking phenoxyisopropanolamine derivatives, also have a strong anagetic effect.

!Særlig i betraktning av anvendelsen som -blokkere ved j 1 1 h' jerteinfarkt, migrene og glaukom har den samtidige analg!e-; ;t! iske virkning øket betydning. ]i !Especially in view of the application as -blockers in j 1 1 h' pancreatic infarction, migraine and glaucoma, the simultaneous analg!e-; ;t! istic effect increased importance. ]in

i (således bevirker f.eks. hydrokloridet av 2,2-dimetyl-4-(21 - 1 i i (thus, for example, the hydrochloride of 2,2-dimethyl-4-(21 - 1 i

jhydroksy-3'-tert.butylaminopropoksy)-1,3-benzodioksol på<j>j ! våkne hunder en 4 0-gangers sterkere svekning av den positive' I Ik' ronotrope isoprenalinvirkning enn den kjente -blokker ji !atenolol i samme dosering og gir i Writhingforsøk ifølgeiHuntingdon med en ED 50 på bare 8 mg/kg (mus, oral) en jhydroxy-3'-tert.butylaminopropoxy)-1,3-benzodioxole on<j>j ! awake dogs a 40-fold stronger weakening of the positive' Ik' ronotropic isoprenaline effect than the known -blocker ji !atenolol in the same dosage and gives in Writhing trials according toiHuntingdon with an ED 50 of only 8 mg/kg (mouse, oral) a

i god analgetisk virkning. Sammenligner man denne i Writhing-:T■estmed tilsvarende for kjente analgetika viser det nye I virkestoff seg å være overlegent: in good analgesic effect. If you compare this in Writhing test with the equivalent for known analgesics, the new active ingredient proves to be superior:

Utgangsproduktene med den generelle formel (II) er enten kjente eller kan fremstilles ved i og for seg kjente metbder. En forbindelse med den generelle formel (II) hvori R, og R„ betyr metyl, anvendes i store mengder som mellomprodukt ved jfremstilling av insekticider (Chem.Abstr. 71, 38941m (1969); i 78 72110u (1973); 84 , 105250u (1976); 85, 192700c (1976)^ The starting products with the general formula (II) are either known or can be prepared by methods known per se. A compound of the general formula (II) in which R, and R„ means methyl, is used in large quantities as an intermediate in the production of insecticides (Chem.Abstr. 71, 38941m (1969); i 78 72110u (1973); 84 , 105250u (1976);85, 192700c (1976)^

I 8 6, 51598j (1977)). I 8 6, 51598j (1977)).

I i In i

' jIjmSbeeeelnkllv aelmr iogpm nnfui: bntger"oWtsmgyidrriukntpstiptnegoelner fn f"e e, ar v 1in k. ejAPn eunfkt flaljpne. rå zne1ane9g8sscur2ohb, uksttjIneizmd- tuuiukssantjd orln iiaSemovcmehed arrdåbdahln aeint lgoPgfse-l(ansanj-mze-n- ' jIjmSbeeeelnkllv aelmr iogpm nnfui: bntger"oWtsmgyidrriukntpstiptnegoelner fn f"e e, ar v 1in k. ejAPn eunfkt flaljpne. raw zne1ane9g8sscur2ohb, uksttjIneizmd- tuuiukssantjd orln iiaSemovcmehed arrdåbdahln aeint lgoPgfse-l(ansanj-mze-n-

;schutz e.V.), og kjernehalogenerte følgeprodukter av forbindelsen med den generelle formel (Ia) er krevet i patenter men ikke beskrevet (AT-PSen 283 812, 296 983) forekommer kjerne-j I substituerte derivater med den generelle formel (Ia) borjtsett I fra et produkt fremstilt ved nitrering av myristicinaldehyd ;schutz e.V.), and core halogenated side products of the compound with the general formula (Ia) are claimed in patents but not described (AT-PSen 283 812, 296 983) core-j I substituted derivatives with the general formula (Ia) occur initially from a product prepared by the nitration of myristicinaldehyde

I (J. Chem.Soc. 95, 1161 (1909)) hittil ikke i faglitteraturen. I (J. Chem.Soc. 95, 1161 (1909)) so far not in the literature.

!Ifølge fremgangsmåten ved fremstilling av forbindelser (Iia) i kan 4-hydroksy-l, 3-benzodioksol enten bare halogeneres ejller Initreres eller først halogeneres og deretter nitreres heh-jholdsvis først nitreres og deretter halogeneres. En først According to the procedure for the preparation of compounds (Iia) in 4-hydroxy-1,3-benzodioxole can either only be halogenated or nitrated or first halogenated and then nitrated, respectively first nitrated and then halogenated. One first

I innført kjernesubstituent kan også i .det derpå følgende I trinn erstattes med et annet. Ved de midler som kan anvendes j for halogenering henholdsvis nitrering dreier det seg om! i i i slike som er i og for seg kjent for omsetning med aromati! skeI In the introduced core substituent can also be replaced by another in the subsequent I step. With the agents that can be used j for halogenation and nitration, it is about! i i i such as are known in and of themselves for sales of aromatics! spoon

I hydrokarboner eller fenoler. In hydrocarbons or phenols.

<I>Kjernesubstituerte pyrogallolderivater med den generellej J ; formel (Ia) kan også tjene til syntese av andre farmakologisk ' i virksomme forbindelser med formel (I) eller for fremstilling av fotosensibilisatorer (sammenlign britisk patent 1 109! 305). Kjernejoderte substanser med den generelle formel (Ia)ejr _ mMfjue.delkiigsshi. entaenn evn esntfodyrr eklaeigns ve veenfd doer klfsjere nemanv ssktasipllelikt ine g tdiael v raivt røadtneetgr n ehninkeonteennrtorfacoyr sktmhluiidmskalneer-. <I>Nuclear substituted pyrogallol derivatives with the generalj J ; formula (Ia) can also serve for the synthesis of other pharmacologically active compounds of formula (I) or for the production of photosensitizers (compare British patent 1 109! 305). Nuclear iodinated substances with the general formula (Ia)ejr _ mMfjue.delkiigsshi. entaenn even esntfodyrr eklaeigns ve veenfd doer klfsjere nemanv ssktasipllekt ine g tdiael v raivt røadtneetgr n ehninkeonteennrtorfacoyr sktmhluiidmskalneer-.

r,ing i humanforsøk ikke oppspaltes (Pestic. Sei. 12, 6|38, 645 (1981)). r,ing in human experiments is not split (Pestic. Sei. 12, 6|38, 645 (1981)).

l l

l Gjennom de følgende eksempler skal oppfinnelsen anskuelig-gjøres nærmere, men ikke begrenses til disse. Temperatur- l Through the following examples, the invention shall be made clearer, but not limited to these. Temperature-

ahgivelsene refererer alltid til celsiusgrader. the data always refer to degrees Celsius.

I IN

1 1

Eksempel 1: 2,2-dimetyl-4-hydroksy-l,3-benzodipksc1 og 22 g NaHC03i 150 ml karbontetraklorid rørt ved 0°C tjil-d.ryppes langsomt 19,24 g brom. Den omsetning som har funnet si ted kan man se på tynnsjiktskromatogram (Sjikt: Kiselgeji<l>6.1 0 F 254 , Eluent: Klor. oform/metanol = 9 : 1). Etter filfe!ring inndampes filtratet pa rotasjonsfordamper. Resten krystalliserer med henstand og kan omkrystalliseres fra petrolejter.Deterholdte 2,2-dimetyl-4-hydroksy-5,7-dibrom-l,3-benzo-diioksol smelter ved 59 - 61°C. Example 1: 2,2-dimethyl-4-hydroxy-1,3-benzodipic acid and 22 g of NaHCO 3 in 150 ml of carbon tetrachloride stirred at 0° C. 19.24 g of bromine are slowly added. The conversion that has been found can be seen on a thin-layer chromatogram (Layer: Silica <l>6.1 0 F 254 , Eluent: Chlor. oform/methanol = 9 : 1). After filtration, the filtrate is evaporated on a rotary evaporator. The residue crystallizes with delay and can be recrystallized from petroleum ether. The 2,2-dimethyl-4-hydroxy-5,7-dibromo-1,3-benzo-diioxole contained therein melts at 59 - 61°C.

Natriumsaltet av denne forbindelsen fås når man blander!en metanolisk løsning med en ekvivalent av en 30%-ig løsning The sodium salt of this compound is obtained by mixing a methanolic solution with an equivalent of a 30% solution

av natrium-metylat i metanol, inndamper blandingen og behandler den faste rest med isopropyleter. Det tørkede natriumsalt smelter ikke opp til 320°C, men blir bare brunfarget. of sodium methylate in methanol, evaporate the mixture and treat the solid residue with isopropyl ether. The dried sodium salt does not melt up to 320°C, but only turns brown.

l Eksempel 2 En løsning av 30 g 2,2-dimetyl-4-hydroksy-l,3-benzodioksbl i'600 ml kloroform avkjølt til -5°C blandes under røringj dråpevis med 14,8 ml av en 65%-ig salpetersyre (D: 1,40)1, l Example 2 A solution of 30 g of 2,2-dimethyl-4-hydroxy-1,3-benzodioxbl in 600 ml of chloroform cooled to -5°C is mixed with stirring dropwise with 14.8 ml of a 65% nitric acid (D: 1.40)1,

hvorved temperaturen stiger til +2 oC. På tynnsjiktkromatbgram whereby the temperature rises to +2 oC. On thin layer chromate bgram

(Sjikt: Kiselgel 60 F 254, Eluent: Kloroform/metanol = 9 : i)(Layer: Silica gel 60 F 254, Eluent: Chloroform/methanol = 9 : i)

kan man så se to nye produkter, hvorav et (5-nitroderivat) j 1'■ igger rett over utgangspunktet og eo t (7-nitroderivat) r^i etti I under. Man lar reagere ferdig ved 10 C og ekstraherer såj tre ganger med vann, hvorunder begynnende krystallisasjon i kan fastslås. Ved inndampning av løsningen som er oppvarmet i I ! i o■g filtrert med aktivt karbon og celitt krystalliserer det i tyngre løselige 2,2-dimetyl-4-hydroksy-7-nitro-l,3-benzo-! dioksol ut. Dette smelter etter omkrystallisering fra CHC1-. one can then see two new products, one of which (5-nitro derivative) j 1'■ igger directly above the starting point and eo t (7-nitro derivative) r^i etti I below. The reaction is allowed to finish at 10 C and the mixture is then extracted three times with water, during which initial crystallization can be determined. By evaporation of the solution heated in I ! in o■g filtered with active carbon and celite it crystallizes in heavier soluble 2,2-dimethyl-4-hydroxy-7-nitro-1,3-benzo-! dioxol out. This melts after recrystallization from CHC1-.

lved 193-195°C. lved 193-195°C.

i i in i

I ; In ;

I For å isolere 5-nitroderivater inndampes CHCl^-moderlutene i til tørrhet, og resten opptas i isopropanol. Når løsningen'står kaldt krystalliserer 2,2-dimetyl-4-hydroksy-5-nitropl,3- In order to isolate 5-nitroderivatives, the CHCl3 mother liquors are evaporated to dryness, and the residue is taken up in isopropanol. When the solution is cold, 2,2-dimethyl-4-hydroxy-5-nitropl,3-

benzodioksol ut, hvilket smelter ved 150-151°C. benzodioxole out, which melts at 150-151°C.

Nitrogruppenes stilling fremgår av NMR-spektrene til de toI isomere: Mens OH-gruppene til 5-nitroderivatet i CDCl^ved 2-50 MHz viser et signal ved 10,42 ppm, viser OH-gruppen til The position of the nitro groups is evident from the NMR spectra of the two isomers: While the OH groups of the 5-nitro derivative in CDCl^ at 2-50 MHz show a signal at 10.42 ppm, the OH group of

7pnitroforbindelsen under sainme betingelser en glidende resonans mellom 4,6 og 6,2 ppm. The 7pnitro compound under the same conditions has a sliding resonance between 4.6 and 6.2 ppm.

i in

Begge isomerer gir oppvarming i vandig løsning som følge av hydrolyse av dioksolanringen det kjente 4-nitro-pyrogallol, Both isomers give heating in aqueous solution as a result of hydrolysis of the dioxolane ring the known 4-nitro-pyrogallol,

smp.: 165 - 166°C (Litteratur: Fp. 162°C). m.p.: 165 - 166°C (Literature: Fp. 162°C).

i in

Eksempel 3 Example 3

En løsning av 5 g av det i eksempel 1 fremstilte natriumj-s■ alt av 2,2-dimetyl-4-hydroksy-5,7-dibo rom-l,3-benzodiokspil il 10<0>ml kloroform blandes ved 0 til 5 C dråpevis med 2,4 ml kons. HNO^. Derunder faller først en felling ut, som i s.tor grad igjen går i oppløsning. Den orangerød blandingen rystes flere ganger uten vann, kloroformfasen tørkes emd| N.a2SO^, filtreres etter røring med aktivt karbon og inndampes i' vakuum. Den gjenværende olje krystalliserer ved røring med vann. Etter omkrystalliseringen av råproduktet fra eddikester får man 2,2-dimetyl-4-hydroksy-5-nitro-7-brom-l,3-benzo- A solution of 5 g of the sodium j-s■ all of 2,2-dimethyl-4-hydroxy-5,7-diborom-1,3-benzodioxypil in 10<0>ml of chloroform is mixed at 0 to 5 C dropwise with 2.4 ml conc. HNO^. Underneath, a precipitate first falls out, which to a large extent again dissolves. The orange-red mixture is shaken several times without water, the chloroform phase is dried N.a2SO^, filtered after stirring with active carbon and evaporated in vacuo. The remaining oil crystallizes on stirring with water. After recrystallization of the crude product from acetic ester, 2,2-dimethyl-4-hydroxy-5-nitro-7-bromo-1,3-benzo-

dioksol som gult pulver med et smp. 93 - 95°C. dioxol as a yellow powder with a m.p. 93 - 95°C.

Avspaltningen av bromidet under omsetningen kan påvises jved reaksjon med AgNO^. N02-gruppens stilling fremgår av NMR- i spekteret (CDC1j .,, 250 MHz) fordi den nabostående OH-gruppi e ii The separation of the bromide during the reaction can be demonstrated by reaction with AgNO^. The N02 group's position is evident from the NMR- i spectrum (CDC1j .,, 250 MHz) because the neighboring OH group e ii

viser et signal ved 10,27 ppm (sammenlign eksempel 2). shows a signal at 10.27 ppm (compare Example 2).

i in

Eksempel 4. T,il en blanding av 3 g 2, 2-dimetyl-4-hydroksy-7-nitro-l ,j3-benzodioksol fremstilt ifølge eksempel 2 drypper man under røring v: ed 0 o C en løsning av 4 g brom i 20 ml CCl^. Etter oppvaI rmin1g til romtemperatur får blandingen stå natten over. På tynnsjiktskromatogram kan man konstatere fullstendig omsetning. Etter filtrering av uorganisk materiale inndampes filtratet i' vakuum og den krystallinske rest omkrystalliseres fra ilitt kloroform. Det erholdte 2,2-dimetyl-4-hydroksy-5-brom-7-j nitro-1,3-benzodioksol smalter ved 185 - 188°C etter at | det har vist en krystallomvandling ved 155°C. _ _| Example 4. To a mixture of 3 g of 2,2-dimethyl-4-hydroxy-7-nitro-1,3-benzodioxole prepared according to example 2, a solution of 4 g of bromine is added dropwise while stirring at 0 o C in 20 ml of CCl^. After warming to room temperature, the mixture is allowed to stand overnight. A thin-layer chromatogram shows complete turnover. After filtration of inorganic material, the filtrate is evaporated in vacuo and the crystalline residue is recrystallized from illite chloroform. The obtained 2,2-dimethyl-4-hydroxy-5-bromo-7-j nitro-1,3-benzodioxole melts at 185 - 188°C after | it has shown a crystal transformation at 155°C. _ _|

Vjed oppvarming av en vandig løsning av denne forbindelse! Avoid heating an aqueous solution of this compound!

dannes som følge av hydrolyse av dioksalanringen det såmne is formed as a result of hydrolysis of the dioxalane ring that sow

I Q In Q

4;-brom-6-nitro-pyrogallol (Smp. 133 - 135 C) som også dannes 4;-bromo-6-nitro-pyrogallol (M.P. 133 - 135 C) which is also formed

I I ved hydrolyse av isomerene erholdt ifølge eksempel 3. I I by hydrolysis of the isomers obtained according to example 3.

! !

i Eksempel 5in Example 5

! En løsning av 10 g 2 ,2-dimetyl-4-hydroksy-l,3-benzodioksol J i! 100 ml kloroform blandes under røring ved 12 til 14°C J idl jråpevis med 10 ml 65%ig HNO-. og etter 15 minutter ved saImme j temperatur med ytterligere 48 ml 65%-ig HNO^. På tynnsjikts-I kromatogram (sammenlign eksempel 2) kan man se at de først ! A solution of 10 g of 2,2-dimethyl-4-hydroxy-1,3-benzodioxole J i! 100 ml of chloroform are mixed with stirring at 12 to 14°C J idl dropwise with 10 ml of 65% HNO-. and after 15 minutes at the same temperature with a further 48 ml of 65% HNO^. On the thin-layer I chromatogram (compare example 2) you can see that they first

i 1 I ! dannede mononitrerte produkter går over i et som sogar ligger in 1 I ! formed mononitrated products pass into one that is even lying

j under 7-nitroderivatet. Man ryster kloroformløsningen etter ytteligere 15 minutters reaksjonstid tre ganger med vann, tørker over Na2SO^ og inndamper filtratet i vakuum. Resten krystalliserer ved riving med isopropanol. Omkrystallisert j under the 7-nitro derivative. After a further 15 minutes of reaction time, the chloroform solution is shaken three times with water, dried over Na2SO4 and the filtrate evaporated in vacuo. The residue crystallizes by trituration with isopropanol. Recrystallized

■fra etanol smelter det erholdte 2,2-dimetyl-4-hydroksy-I 5.7-dinitro-l,3-benzodioksol ved 203 - 205°C. ■from ethanol the obtained 2,2-dimethyl-4-hydroxy-15,7-dinitro-1,3-benzodioxole melts at 203 - 205°C.

i in

I ' I'

j Eksempel 6j Example 6

i i in i

: En løsning av 10 g 2 , 2-dimetyl-4-hydroksy--l, 3-benzodiaoksol : A solution of 10 g of 2,2-dimethyl-4-hydroxy--1,3-benzodiaxole

:i il ! ii 200 ml CC1. blandes med 20 g av en pulverisert kationujtbytJ- :i il ! ii 200 ml of CC1. mixed with 20 g of a powdered cation exchange

I ! teir (med -COONa som aktive grupper) og dertil tilsettes drå-! !peivis under omrøring ved romtemperatur en løsning av 5,4 ml jsulfurylklorid i 20 ml CC1.. Etter 3 timer tildrypper man I! teir (with -COONa as active groups) and to that is added drå-! !peivis with stirring at room temperature a solution of 5.4 ml of sulfuryl chloride in 20 ml of CCl.. After 3 hours, add dropwise

I II In II

I ytterligere en løsning av 2,7 ml S0,,C12i 10 ml CCl^. Etter i ytterligere 3 timers røring viser tynnsjiktskromatogram I j ! (srnl. eksempel 1) nesten fullstendig omsetning. Den av ione-j '.utbytteren frasugde løsning vaskes med vann, tørkes sicc'. In another solution of 2.7 ml of S0,,C12 in 10 ml of CCl^. After a further 3 hours of stirring, the thin-layer chromatogram shows I j ! (srnl. example 1) almost complete turnover. The solution sucked off by the ion exchanger is washed with water, dried sicc'.

i ■ ' 11i over Na2SOijog inndampes. Ved omkrystallisasjon av resten frja i ■ ' 11i over Na2SOijog is evaporated. By recrystallization of the residue from

petroleter under anvendelse av aktivt karbon får man 2,27-dimetyl-4-hydroksy-5-klor-l,3-benzodioksolet med frysepunkt petroleum ether using activated carbon gives 2,27-dimethyl-4-hydroxy-5-chloro-1,3-benzodioxole with freezing point

!81-83°C. !81-83°C.

i i in i

i Kloratomets stilling er resultatet av at begge de aromatiske in the chlorine atom's position is the result that both the aromatic

1 j pav ri ontoanterir umi fNeMnoR-laspteekt ti reCt D^(OCDD Ce1l-.l, er 250 av MHezt )k, oompgsleå kes tmteed r dean nne|eulros|e- 1 j pav ri ontoanterir umi fNeMnoR-laspteekt ti reCt D^(OCDD Ce1l-.l, is 250 of MHezt )k, oompgsleå kes tmteed r dean nne|eulros|e-

pi, um-forbindelse praktisk talt ikke oppviser noen "shift1'1- pi, um connection practically does not exhibit any "shift1'1-

'virkning. 'effect.

Eksempel 7 Example 7

Én løsning av 5 g 2,2-dimetyl-4-hydroksy-l, 3-benzodiokscjl i 100 ml CCl^ blandes med et jodkrystall og 10 g natriumbikar--lionat og kjøles til 0°C. Dertil tildrypper man under røJing yed 0 - 3°C en løsning av 8,5 g klor i 80 ml CC14. Såsnart intet utgangsprodukt ikke lenger opptrer ved tynnsjiktskromatogram (sml. eksempel ), fjerner man overskytende klorj<y>ed innblåsing av nitrogen. Filtratet av reaksjonsblandingen inndampes i vakuum og resten røres med petroleter, hvorpå krystallisasjon setter inn. Råproduktet felles ut under anvendelse av aktivt karbon fra metanol/vann. Således fåjr One solution of 5 g of 2,2-dimethyl-4-hydroxy-1,3-benzodioxycycline in 100 ml of CCl 2 is mixed with an iodine crystal and 10 g of sodium bicarbonate and cooled to 0°C. A solution of 8.5 g of chlorine in 80 ml of CC14 is added drop by drop while stirring at 0 - 3°C. As soon as no starting product no longer appears in a thin-layer chromatogram (cf. example), excess chlorine is removed by blowing in nitrogen. The filtrate of the reaction mixture is evaporated in vacuo and the residue is stirred with petroleum ether, after which crystallization sets in. The crude product is precipitated using activated carbon from methanol/water. Thus few

nian et fargeløst pulver av 2 , 2-dimetyl-4-hydroksy-5 , 6 , 7-tri-klor-1,3-benzodioksol, som smelter ved 150-152°C. nian a colorless powder of 2 , 2-dimethyl-4-hydroxy-5 , 6 , 7-tri-chloro-1,3-benzodioxole, which melts at 150-152°C.

I denne forbindelses NMR-spektrum finnes ingen signaler Iifor| In the NMR spectrum of this compound, there are no signals for Ii|

kjerneprotoner. nuclear protons.

Eksempel 8 Example 8

Til en løsning av 8,4 g 2 ,2-dimetyl-4-hydroksy-l, 3-benzO|di- j oksol i 400 ml 0,5 n NaOH tildrypper man under røring ved romtemperatur en løsning av 25,4 g jod og 30 g kaliumjodid i; 150 ml vann. Etter henstand over natten kan ved tynnsjlkts-kromatogram (sjikt: kiselgel 60 F 254, løpemiddel: etylace-' tat/metanol/2n NH^OH = 25 : 8 : 3) dannelsen av et nytt produkt fastslås. Den filtrerte løsning røres ved 2-5°C med mettet vandig NaHSO,-løsning inntil pH 5, og rystes deretter u1 t med kloroform. Den med NaSO^tørkede og etter tilsetniing ; av aktivt karbon filtrerte kloroformløsning etterlater s'eg i etter inndampning en gul olje. Etter ..utfelling fra metanol/! vann eller omkrystallisasjon fra petroleter får man 2,2-dI i-',i metyl-4-hydroksy-5 , 7-dijod-l, 3-benzodioksol med smp. 52-55°C .: Eksempel 9 A solution of 25.4 g of iodine is added dropwise while stirring at room temperature to a solution of 8.4 g of 2,2-dimethyl-4-hydroxy-1,3-benzO|dioxol in 400 ml of 0.5 N NaOH and 30 g of potassium iodide in; 150 ml of water. After standing overnight, the formation of a new product can be determined by thin-layer chromatogram (layer: silica gel 60 F 254, eluent: ethyl acetate/methanol/2n NH 2 OH = 25 : 8 : 3). The filtered solution is stirred at 2-5°C with saturated aqueous NaHSO 3 solution until pH 5, and then shaken for 1 h with chloroform. The with NaSO^ dried and after addition ; of active carbon filtered chloroform solution leaves a yellow oil after evaporation. After ..precipitation from methanol/! water or recrystallization from petroleum ether gives 2,2-dI i-',i methyl-4-hydroxy-5,7-diiodo-1,3-benzodioxole with m.p. 52-55°C.: Example 9

En blanding av 12,2 g 2,2-dimetyl-4-hydroksy^l,3-benzodiok- j A mixture of 12.2 g of 2,2-dimethyl-4-hydroxyl,3-benzodioc-

I i sol, 24 g NaHC03, 0,05 g FeCl3og 400 ml tetraklorkarbon) | tildryppes under røring ved 0 o C en løsning av 11 g klor 'i ■ 150 ml CCl^. Såsnart tynnsjiktskromatogrammet (sml. eksempel 8) viser fullstendig omsetning, filtreres blandingen og f il-tri atet inndampes. Resten felles ut etter filtrering av. lø!s- .J riingen med aktivt karbon fra metanol/vann, og omkrystalljise-res derpå fra isopropyleter/petroleter. Man får således 2,24 I in sol, 24 g NaHCO3, 0.05 g FeCl3 and 400 ml carbon tetrachloride) | a solution of 11 g chlorine in ■ 150 ml CCl^ is added dropwise while stirring at 0 o C. As soon as the thin-layer chromatogram (see example 8) shows complete reaction, the mixture is filtered and the filtrate is evaporated. The rest is precipitated after filtering. The solution is dissolved with activated carbon from methanol/water, and then recrystallized from isopropyl ether/petroleum ether. You thus get 2.24

dimetyl-4-hydroksy-5,7-diklor-l,3-benzodioksol med smp. dimethyl-4-hydroxy-5,7-dichloro-1,3-benzodioxole with m.p.

I IN

1i72-17<4>°C. i 1i72-17<4>°C. in

Dsee g tore gskå jeskrnielkle lorfera rte hvdeerarnivdare tevr ed frda eereks semRpfe-vl er6i, d7 . oUg nde9 r<ljb>aer-Dsee g tore gskå jeskrnielkle lorfera rte hvdeerarnivdare tevr ed frda eereks semRpfe-vl er6i, d7 . oUg nde9 r<ljb>aer-

tingelsene for det i eksempel 8 beskrevne tynnsjiktskroma- the conditions for the thin-layer chroma described in example 8

tlo<g>ramfår man: tlo<g>ram you get:

Eksempel 10 En løsning av 113,5 g 2 , 2-dimetyl-4-hydroksy-1,3-benzodioksol i 400 ml metnaol blandes dråpevis under røring med 123 g av en 30%'ig løsning av natriummetylat i metanol, hvor<I>ved blandingen blir mørkfarget. Den ved inndampning på rotas<i><j>ons■-fordamperen ved 50 o C erholdte olje (140 g) tas opp i 180 ml•<j>epiklorhydrin og løsningen røres i 3 timer ved 55°C etter tilsetning av 15 g benzyltrietyl-ammoniumklorid. Ved tynn- i sjiktskromatogram (ferdigplate: kiselgel 60 F 254, løpemid-del: benzen/dioksan/iseddik, 90 : 25 : 4 vol.deler) kan man ikke lenger påvise noe utgangsprodukt. Overskytende epiklor-j hydrid dampes av på rotasjonsfordamperen ved 60°C og resten tas opp i varmt etylacetat. Etter tilsetning av noe akti'vt karbon til den kjølte løsning suger man av gjennom Celite-filterhjelpemiddel og inndamper filtr.' atet i vakuum. Man |i få. ri således 151 g (99,5 %) rått 2 , 2-dimety 1-4-(2 ' , 3 '-epoksy-j propoksy)-1,3-benzodioksol som gul olje, som er tilstrekke-| lig ren for videre omsetning med baser. i I<i>\I I ! 10 g rått 2,2-dimetyl-4-(2',3<1->epoksy-propoksy)-1,3-benzpdi-oksol oppvarmes i 20 ml etanol etter tilsetning av 10 ml| tert.butylamin i 3 timer under tilbakeløp. En prøve viseri Example 10 A solution of 113.5 g of 2,2-dimethyl-4-hydroxy-1,3-benzodioxole in 400 ml of methanol is mixed dropwise with stirring with 123 g of a 30% solution of sodium methylate in methanol, where >when the mixture becomes dark colored. The oil obtained by evaporation on the rotas<i><j>ons■ evaporator at 50 o C (140 g) is taken up in 180 ml •<j>epichlorohydrin and the solution is stirred for 3 hours at 55°C after the addition of 15 g benzyltriethylammonium chloride. With a thin-layer chromatogram (finished plate: silica gel 60 F 254, eluent: benzene/dioxane/glacial acetic acid, 90 : 25 : 4 vol.parts) no starting product can be detected anymore. Surplus epichlor-j hydride is evaporated on the rotary evaporator at 60°C and the residue is taken up in hot ethyl acetate. After adding some active carbon to the cooled solution, it is sucked off through a Celite filter aid and the filter is evaporated. ate in vacuum. One |in few. thus 151 g (99.5%) of crude 2,2-dimethyl 1-4-(2',3'-epoxy-j propoxy)-1,3-benzodioxole as a yellow oil, which is sufficiently ready for further turnover with bases. i I<i>\I I ! 10 g of crude 2,2-dimethyl-4-(2',3<1->epoxy-propoxy)-1,3-benzpdioxole are heated in 20 ml of ethanol after the addition of 10 ml| tert.butylamine for 3 hours under reflux. A sample visa

i in

derpå ved tynnsjiktskromatogram (ferdigplate: kiselgel 60 Fl then by thin-layer chromatogram (finished plate: silica gel 60 Fl

2-5 4, løpemiddel: eddikester/metanol) 2n NH.OH, 25 : 8 : 31 2-5 4, eluent: ethyl acetate/methanol) 2n NH.OH, 25 : 8 : 31

- y' olumdeler) fullstendig omsetning. Man inndamper løsningienpå rotasjonsfordamper ved 50 C, opptar den oljeaktige reist i i noe eddikester og inndamper igjen. Den erholdte olje lIøses i eddikester og løsningen vaskes ved utrystning med mettet vjandig NaCl-løsning. Deretter ekstraherer man eddikesterjløs-ningen med 2n HC1, filtrerer den sure vandige løsnina etlter tilsetning av aktivt karbon, gjør filtratet alkalisk med! 5n NaOH til pH 10 og ekstraherer flere ganger med kloroform. Den med Na2S04 tørkete kloroformløsning etterlater seg en en olje etter inndampningen, hvilken krystalliserer ved henstand. Omkrystallisert fra n-heksan får man 10,5 g (79 %j av det teoretiske) fargeløse krystaller av 2,2- dimety 1-4-(|2 ' - hydroksy-3'-tert.butylaminopropoksy)-1,3-benzodioksol med - y' olumdeler) complete turnover. The solution is evaporated on a rotary evaporator at 50 C, the oily residue is taken up in some vinegar and evaporated again. The oil obtained is dissolved in vinegar and the solution is washed by shaking with saturated aqueous NaCl solution. The acetic acid solution is then extracted with 2n HC1, the acidic aqueous solution is filtered and activated carbon is added, the filtrate is made alkaline with! 5n NaOH to pH 10 and extract several times with chloroform. The chloroform solution dried with Na2S04 leaves behind an oil after evaporation, which crystallizes on standing. Recrystallized from n-hexane gives 10.5 g (79% of the theoretical) colorless crystals of 2,2-dimethyl 1-4-(|2 '-hydroxy-3'-tert.butylaminopropoxy)-1,3- benzodioxol with

smp. 75-7 6°C. m.p. 75-76°C.

i in

I IN

Denne forbindelses hydroklorid feller ut fra en isopropyl-e1 ter—løsning ved blanding med alkoholisk HC1. Omkrystall!i<->i : sert fra isopropanol smelter hydrokloridet ved 124-126 o C'. The hydrochloride of this compound precipitates from an isopropyl ether solution when mixed with alcoholic HCl. Recrystallized from isopropanol, the hydrochloride melts at 124-126 o C'.

J Eksempel li J Example li

I En løsning av 10 g av ået ifølge eksempel 10 oppnåelige jl,3-jbenzodioksol-utgangsprodukt i 20 ml etanol blandes med 8^,24 I A solution of 10 g of the 1,3-benzodioxole starting product obtainable according to example 10 in 20 ml of ethanol is mixed with 8^,24

i g benzhydrylamin og kokes 5 timer under tilbakeløpsk jøli.ng. j Resten som blir tilbake etter inndampning av blandingen Iitas ' opp i noe aceton og løsningen blandes med alkoholisk HC1<1>i samt isopropyleter. Det ved dette utfellende oljeaktige;bunn-I fall blir krystallinsk ved henstand. Etter omkrystallisasjo— in g of benzhydrylamine and boiled for 5 hours under reflux. j The residue that remains after evaporation of the mixture is dissolved in some acetone and the solution is mixed with alcoholic HCl and isopropyl ether. The oily bottom that precipitates becomes crystalline on standing. After recrystallization—

<>><n>en fra isopropanol (under anvendelse av aktivt karbon og | I filtrering) får man 18 g (90,5 %) hydroklorid av 2,2-dimetyl-I ! li i 4-(2'-hydroksy-3'-difeny1-metylamino-propoksy)-1,3-benzodi- <>><n>en from isopropanol (using activated carbon and | I filtration) gives 18 g (90.5%) hydrochloride of 2,2-dimethyl-I ! li i 4-(2'-Hydroxy-3'-diphenyl-1-methylamino-propoxy)-1,3-benzodi-

'oiksol, som smelter ved 136-139°C. 'oiksol, which melts at 136-139°C.

i in

i in

; Eksempel 12; Example 12

I En løsning av 10 g av det ifølge eksempel 10 oppnåelige :1,3-r I A solution of 10 g of the :1,3-r obtainable according to example 10

benzodioksol-utgangsprodukt og 4,15 g 2-metyl-3-butin-2-,yl- | amin (90%'ig) i 20 ml etanol lar man stå 3 dager ved romtemperatur. Inndampningsresten cbppløses i dietyleter og løsnin-gfern a. bDleanndnee s lmøesed s ali kovhaorm lisak ceHtCon1, . hVveod rvaevd kjøen liong lje utkskryisltlear llli:siesge- benzodioxole starting product and 4.15 g of 2-methyl-3-butyn-2-,yl- | amine (90%) in 20 ml of ethanol is allowed to stand for 3 days at room temperature. The evaporation residue is dissolved in diethyl ether and the solvent is removed. hVveod rvaevd the queue liong lje utskskryisltlear llli:siesge-

I ! il rer hydrokloridet av 2,2-dimety1-4-[2'-hydroksy-3'-(2"-metylL I! The hydrochloride of 2,2-dimethyl-4-[2'-hydroxy-3'-(2"-methyl)

3''-butin-2"-ylamino)-propoksy]-1, 3-benzodioksol. Smp. 153- 3''-butyn-2"-ylamino)-propoxy]-1, 3-benzodioxole. Mp. 153-

155 C. Utbytte: 12,5 g (81,3%). 155 C. Yield: 12.5 g (81.3%).

i Utbytte: 12,5 g i Yield: 12.5 g

i [ Eki sempel 13 in [ Eki sample 13

En løsning av 22,1 g 2-metoksy-2-mety1-4-hydroksy-l,3-benzo-i I dioksol i 60 ml metanol blandes under røring dråpevis med A solution of 22.1 g of 2-methoxy-2-methyl-4-hydroxy-1,3-benzo-1 dioxol in 60 ml of methanol is mixed dropwise with stirring

21i ,8 g av en 30%'ig løsning av natriummetylat i metanol, hvori-ved blandingen farges mørk. Den ved inndampning på fotasjonsj- 21 in .8 g of a 30% solution of sodium methylate in methanol, whereby the mixture is colored dark. The by evaporation on photic j-

fo! rdamper ved 50°C erholdte olje opptas i 50 ml epiklorhyId-rin og blandingen røres etter tilsetning av 3,5 g benzyly fo! rvapor at 50°C oil obtained is taken up in 50 ml of epichlorhydrin and the mixture is stirred after adding 3.5 g of benzyl

Itrietylammoniumklorid i 3 timer ved 60°C. Man avdamper over- Ytriethylammonium chloride for 3 hours at 60°C. One evaporates over-

tsåki yr ternedse ten epoikpp loi rhyvdarrmit n peå tylroacteastajton. sEfottredar mpteilresn etvneid ng 60 av C noo!eg Ij aktivt karbon til den kjølte løsning suger man fra ved Cé- tsåki yr ternedse ten epoikpp loi rhyvdarrmit n peå tylroacteastajton. sEfottredar mpteilresn etvneid ng 60 of C noo!eg Ij active carbon to the cooled solution is sucked off by C-

Ilite-filterhjelpemiddel og inndamper filtratet i vakuum. Man Ilite filter aid and evaporates the filtrate in a vacuum. Mon

jfår således 28,5 g (98,6 %) rått 2-metoksy-2-mety1-4-(2S3'-iepoksypropoksy)-1,3-benzodioksol som brun olje, som er til-i js-tirekkelig ren for videre omsetning med baser. thus obtaining 28.5 g (98.6%) of crude 2-methoxy-2-methyl-4-(2S3'-iepoxypropoxy)-1,3-benzodioxole as a brown oil, which is sufficiently pure for further turnover with bases.

En løsning av 10 g 2-metoksy-2-metyl-4-(2 ' , 3 '-epoksy-prop: ok-j! sy)-1,3-benzodioksol i 20 ml etanol oppvarmes etter tilset-Ining av 10 ml isopropylamin under tilbakeløpskjøling inntil jen prøve på tynnsjiktskromatogram (ferdigplate: kiselgelj 60 j I1 G{• 2 54, løpemiddel: kloroform/metanol, 9 : 1 volumdeler eli ler! ! 1edi dikester/metanol/2n NH 4 OH, 25 : 8 : 3 volumdeler) viser i | [fullstendig omsetning. Den etter inndampningen av løsningen A solution of 10 g of 2-methoxy-2-methyl-4-(2',3'-epoxy-prop:oc-j!sy)-1,3-benzodioxole in 20 ml of ethanol is heated after the addition of 10 ml isopropylamine under reflux until jen sample on thin-layer chromatogram (finished plate: silica gel 60 j I1 G{• 2 54, eluent: chloroform/methanol, 9 : 1 parts by volume eli ler! ! 1edi diester/methanol/2n NH 4 OH, 25 : 8 : 3 volume fractions) shows in | [complete turnover. The one after the evaporation of the solution

i !ptoå n roog tabs ljoannds efos rmdeamd peen r tløislbnaikneg balv ive8n,d5 e g røcyde kloohlejke sylølsseus lfai m^ince- -|j i !ptoå n roog tabs ljoannds efos rmdeamd peen r tløislbnaikneg balv ive8n,d5 e g røcyde kloohlejke sylølsseus lfai m^ince- -|j

i I syre i aceton. Ved henstand av blandingen ved 4 C krystali li-I jserer cyklamatet av 2-metoksy-2-metyl-4-(2'-hydroksy-3'- j iisopropylamino-propoksy)-1,3-benzodioksol, som etter omkry- j in I acid in acetone. On standing of the mixture at 4 C, the cyclamate of 2-methoxy-2-methyl-4-(2'-hydroxy-3'-isopropylamino-propoxy)-1,3-benzodioxole, which after cross-

j ! st 1 allisas jon fra isopropanol smelter ved 139-142°C. Utbytte:}i I i 12! ,6 g (63 % av det teoretiske). !j y! st 1 allisate ion from isopropanol melts at 139-142°C. Dividend:}i I i 12! .6 g (63% of the theoretical). !j

\ Eksempel 14 j i: En løsning av 10 g av det ifølge eksempel 10 oppnåelige 2,2-; dimetyl-4-(2',3'-epoksy-propoksy)-1,3-benzodioksol i 20 ml \ Example 14 j i: A solution of 10 g of the 2,2- obtainable according to example 10; dimethyl-4-(2',3'-epoxy-propoxy)-1,3-benzodioxole in 20 ml

-etanol oppvarmes etter tilsetning av 10 ml isopropylamin| i__ -ethanol is heated after adding 10 ml of isopropylamine| in__

3 i timer under tilbakeløpskjøling og inndampes deretter i va-*i kjuum. Den slik erholdte gule olje tar man opp i isopropyletér. Ved blanding av løsningen med alkoholisk HC1 filer hydroklo-J ridet av 2 ,2-dimetyl-4-(2 ' -hydroksy-3 '-isopropylamino-prjopo)< - s'y)-1, 3-benzodioksol ut (12,0 g, 83,9 %), som etter omkrystallisasjon fra isopropanol smelter ved 157-159°C. Den jtil-j 3 for hours under reflux and then evaporated in va-*i kjuum. The yellow oil thus obtained is taken up in isopropyl ether. On mixing the solution with alcoholic HCl, the hydrochloride of 2,2-dimethyl-4-(2'-hydroxy-3'-isopropylamino-propyl)-1,3-benzodioxole precipitates out (12, 0 g, 83.9%), which after recrystallization from isopropanol melts at 157-159°C. The jtil-j

svarende frie base smelter ved 91-93°C. corresponding free base melts at 91-93°C.

I; en løsning av 10 g av det erholdte hydroklorid i 140 ml destillert vann innføres under omrøring porsjonsvis 20 g| av en finpulverisert polystyren-kationutbygger, som inneholder IN; a solution of 10 g of the hydrochloride obtained in 140 ml of distilled water is introduced with stirring in portions of 20 g| of a finely powdered polystyrene cation developer, which contains

-SO^Na som aktive grupper. Man rører ytterligere 24 timejr, suger fra, vasker fellingen på filter flere ganger med destillert vann og får etter tørking i vakuum ved 70°C 25,,5 g -SO^Na as active groups. Stir for a further 24 hours, suck off, wash the precipitate on the filter several times with distilled water and, after drying in a vacuum at 70°C, obtain 25.5 g

r^esinat. r^esinate.

Etter oral administrasjon av dette resinat f.eks. i magejsaft- After oral administration of this resinate e.g. in gastric juice

resistente kapsler frigis det virksomme stoff forsinket. resistant capsules release the active substance delayed.

Eksempel 15 Example 15

En blanding av 20 g p-klorfentermin-hydroklorid, 150 ml i jmet-ji tet NaHCO-j-løsning og 200 ml kloroform røres intensivt 1: ti4 me, derpå skilles fasene, CHClj ^-fasen tørkes sicc. over ! l Na-jSO^ og inndampes i vakuum, p-klorfentermin-basen ble jer- j A mixture of 20 g of p-chlorphentermine hydrochloride, 150 ml of saturated NaHCO-j solution and 200 ml of chloroform is stirred intensively for 1:14 me, then the phases are separated, the CHClj^-phase is dried sicc. above ! l Na-jSO^ and evaporated in vacuo, the p-chlorphentermine base became jer- j

h! oldt som gullig olje. j ! h! old as yellow oil. y!

8,3 g av denne olje ble oppvarmet med 10 g av det ifølge: eksempel 10 oppnåelige 2,2-dimety1-4-(2<1>,3'-epoksy-propoksy)-i j 8.3 g of this oil was heated with 10 g of the 2,2-dimethyl-4-(2<1>,3'-epoxy-propoxy)-i j obtainable according to: example 10

1,3-benzodioksol i 20 ml etanol i 8 timer under tilbakeløp. j Den etter inndampningen av løsningen på rotasjonsfordamper tilbakeblivende gullige olje ble tatt opp i aceton og løs-ningen blandet med alkoholisk HC1. Det ved dette utfelte' i 1,3-benzodioxole in 20 ml of ethanol for 8 hours under reflux. j The yellowish oil remaining after the evaporation of the solution on a rotary evaporator was taken up in acetone and the solution mixed with alcoholic HC1. That by this precipitated' i

i hydroklorid av 2 , 2-dimetyl-4-[ 3 ' - (a , a-dimetyl-p-klorf ene|tyl-i in hydrochloride of 2,2-dimethyl-4-[3'-(a,a-dimethyl-p-chlorophenethyl-i

amino)-2 '-hydroksy-propoksy ]-1, 3-benzodioksol (15,7 g, 7.8 , 9 ! amino)-2'-hydroxy-propoxy]-1,3-benzodioxole (15.7 g, 7.8 , 9 !

%) ble omkrystallisert fra etanol. Smp. 212-215°C. %) was recrystallized from ethanol. Temp. 212-215°C.

Etter fremgangsmåter som er analoge med de beskrevet i eksemplene 10 - 15, ble ytterligere derivater med den generelle formel (Ib) erholdt. Disse er sammenstilt i de følgende_Jta-_ beiler I og II. Following procedures analogous to those described in Examples 10-15, further derivatives of the general formula (Ib) were obtained. These are compiled in the following_Jta-_ beiler I and II.

Eksempel 16 a.) En blanding av 120 g 2 , 2-dimety 1-4-hydroksy-l, 3-benzpdi--ioksol, 319,6 g allylbromid, 533 g K^ SO^ og 2600 ml aceton i kokes i 5 timer under tilbakeløp og filtreres derpå- Filtra--: tets inndampningsrest rystes med isopropyletér og fortyninet jNaOH, eterløsningen vaskes med vann, tørkes sicc. med Na2S04; og filtreres etter behandling med aktivt karbon. Ved inndamp-I ning av filtratet får man en grønnlig-gul olje som koker j I ved 122-124°C/10 torr og består av 2 ,*2-dimety 1-4-allyloksy- j .1,3-benzodioksol. Utbytte: 132 g (88,6 %). Example 16 a.) A mixture of 120 g of 2,2-dimethyl 1-4-hydroxy-1,3-benzpdi--ioxole, 319.6 g of allyl bromide, 533 g of K^SO^ and 2600 ml of acetone is boiled for 5 hours under reflux and then filtered. The filtrate's evaporation residue is shaken with isopropyl ether and the diluted jNaOH, the ether solution is washed with water, dried sicc. with Na 2 SO 4 ; and filtered after treatment with activated carbon. Evaporation of the filtrate yields a greenish-yellow oil which boils at 122-124°C/10 torr and consists of 2,*2-dimethyl 1-4-allyloxy-j,1,3-benzodioxole. Yield: 132 g (88.6%).

|b.) Man oppvarmer en løsning av 132 g 2,2-dimetyl-4-allylok-i sy-1,3-benzodioksol i 300 g 1,2-diklor-benzen i 4 timer i,un-! der røring til 180°C, ekstraherer den kjølte løsning flere I ganger med ln NaOH, surgjør de forenete vandig-alkaliske' i ekstrakter under kjøling med fortynnet HC1 og ryster straks I ut med kloroform. Den tørkete kloroformløsning etterlater seg etter inndampning 105,3 g (79,8 %) av en gul olje, som |b.) A solution of 132 g of 2,2-dimethyl-4-allyloxy-1,3-benzodioxole in 300 g of 1,2-dichloro-benzene is heated for 4 hours in,un-! where stirring to 180°C, extract the cooled solution several I times with ln NaOH, acidify the combined aqueous-alkaline' in extracts while cooling with dilute HC1 and immediately shake out I with chloroform. The dried chloroform solution leaves after evaporation 105.3 g (79.8%) of a yellow oil, which

består av 2 , 2-dimetyl-4-hydroksy-5-allyl-l, 3-benzodioks'ol.I Rf-verdi på kiselgel 60 F 254 (løpemiddel: kloroform/metanol consists of 2, 2-dimethyl-4-hydroxy-5-allyl-1, 3-benzodioxol. I Rf value on silica gel 60 F 254 (eluent: chloroform/methanol

=9:1) : 0,66. Rf-verdi den for allylomleiring innførte =9:1) : 0.66. Rf value that for allyl rearrangement introduced

allyleter under samme DC-betingelser: 0,73. allyl ethers under the same DC conditions: 0.73.

c1,.) 3-bTeinl zoen dioløkssonl ing i a1v 50 1m05l ,m3 eg tan2o,l 2-dtiimlesteyttle-s 4-hunydderor ksryø-ri5n-ga]llylI-9,1,7 g av en 30%'ig metanolløsning av CH^ONa. Etter 2 timer c1,.) 3-bTeinl zoene dioleksonl ing in a1v 50 1m05l ,m3 eg tan2o,l 2-dtiimlesteyttle-s 4-hunydderor ksryø-ri5n-ga]lylI-9,1.7 g of a 30%' methanol solution of CH^ONa. After 2 hours

inndamper man løsningen, opptar den mørke rest i 100 ml epiklorhydrin under tilsetning av 11,2 g benzyltrietylammonjium-r if the solution is evaporated, the dark residue is taken up in 100 ml of epichlorohydrin while adding 11.2 g of benzyltriethylammonium-r

kilorid, rører 5 timer og lar løsningen stå over natten. kilorid, stirs for 5 hours and leaves the solution overnight.

Inndampningsresten fordeles mellom vann og etylacetat. Eddik-esterløsningen rystes ut ytterligere flere ganger med vann, tørkes og inndampes. Man får således 127 g (94,8 %) 2,2-di-j mety1-4- (2',31-epoksy-propoksy)-5-allyl-l,3-benzodioksol som gul olje, som under de i trinn b.) beskrevne DC-betingelseri The evaporation residue is distributed between water and ethyl acetate. The acetic ester solution is shaken out several more times with water, dried and evaporated. 127 g (94.8%) of 2,2-di-jmethyl-4-(2',31-epoxy-propoxy)-5-allyl-1,3-benzodioxole are thus obtained as a yellow oil, which under the step b.) described DC conditionsi

oppviser en Rf-verdi på 0,74. exhibits an Rf value of 0.74.

I IN

d■ .) 20 g 2,2-dimety1-4-(2',3'-epoksy-propoksy)-5-allyl-li,3<->benzodioksol og 25 ml tert. butylamin røres i 25 ml etanojl i ' i 2! dager ved romtemperatur. Den etter inndampning av løsni in-I I gen erholdte rest tas opp i isopropyletér og løsningen blan-f I des med alkoholisk HC1, hvorpå hydrokloridet av 2,2-dimejty 1-j !4-(2'-hydroksy-3'-tert.butylamino-propoksy)-5-allyl-l,3-j d■ .) 20 g of 2,2-dimethyl-4-(2',3'-epoxy-propoxy)-5-allyl-1,3<->benzodioxole and 25 ml of tert. butylamine is stirred in 25 ml of ethanol in ' i 2! days at room temperature. The residue obtained after evaporation of the solvent is taken up in isopropyl ether and the solution is mixed with alcoholic HCl, after which the hydrochloride of 2,2-dimethyl-1-4-(2'-hydroxy-3'- tert-butylamino-propoxy)-5-allyl-1,3-j

jbénzodioksol feller ut. Etter omkrystallisasjon fra isopro- i pyleter/etylacetat (3 : 1) smelter produktet ved 129 - 1:32°C. jbénzodioxol precipitates. After recrystallization from isopropyl ether/ethyl acetate (3:1), the product melts at 129 - 1:32°C.

j Utbytte: 18,9 g (66,6 %) . j Yield: 18.9 g (66.6 %).

I !Tilsvarende de i eksempel 16 oppførte angivelser får man| ' de ■j In !Corresponding to the entries listed in example 16, one gets| ' they ■j

i1 tabell III oppførte forbindelser. i1 Table III listed compounds.

Eksempel 17 Example 17

Til en løsning av 10 g 2,2-dimetyl-4->hydroksy-l, 3-benzodi- j oksol i 50 ml metanol tildrypper man under røring 10,8 g, av j en 30%'ig løsning av CH^ONa i metanol. Den mørkfargete blan-j ding tilsettes deretter dråpevis en løsning av 12,55 g brom<J>, eddiksyreetylester i 15 ml metanol. Man rører ved romtempe- j råtur inntil tynnsjiktskromatogrammet (sjikt: kiselgel 60 F To a solution of 10 g of 2,2-dimethyl-4->hydroxy-1,3-benzodioxol in 50 ml of methanol, 10.8 g of a 30% solution of CH^ONa is added dropwise while stirring in methanol. The dark colored mixture is then added dropwise to a solution of 12.55 g of bromine ethyl acetate in 15 ml of methanol. Stir at room temperature until the thin-layer chromatogram (layer: silica gel 60 F

254, løpemiddel: kloroform/metanol =9:1) ikke lenger på-viser noe utgangsprodukt, inndamper på rotasjonsfordamperen 254, eluent: chloroform/methanol =9:1) no longer shows any starting product, evaporates on the rotary evaporator

og tar resten opp i kloroform. Den filtrerte kloroformløs-ning rystes ut to ganger med ln NaOH og tre ganger med vann, tørkes over Na^SO^ og inndampes. Det først som olje erholdte and takes up the remainder in chloroform. The filtered chloroform solution is shaken out twice with 1N NaOH and three times with water, dried over Na^SO^ and evaporated. The first that oil obtained

2i2-dimetyl-4-(karbetoksy-metoksy)-1,3-benzodioksol krystal- 2i2-Dimethyl-4-(carbethoxy-methoxy)-1,3-benzodioxole crystal-

liserer ved henstand og smelter derpå ved 46-48°C. lyses on standing and then melts at 46-48°C.

i f in f

I Eksempel 18In Example 18

i i ■ I En løsning av 11,3 g av den ifølge eksempel 17 erholdte ester ji 100 ml etanol tilsettes dråpevis etter tilsetning av 20 ml i vann under røring 8 g av en 30%'ig løsning av CH30Na i meta-'no! l■ . Etter 1 times røring ved romtemperatur viser tynnsjiikts-kromatogrammet (sjikt: kiselgel 60 F 254, løpemiddel: eddik-iester/metanol/2n NH^OH = 25 : 8 : 3) fullstendig omsetning. J Løsningen inndampes i vakuum, resten løses i vann. Det vid ain-I i i ■ I A solution of 11.3 g of the ester obtained according to example 17 in 100 ml of ethanol is added dropwise after the addition of 20 ml in water while stirring 8 g of a 30% solution of CH30Na in meta-'no! l■ . After stirring for 1 hour at room temperature, the thin-layer chromatogram (layer: silica gel 60 F 254, eluent: acetic ester/methanol/2n NH^OH = 25 : 8 : 3) shows complete reaction. J The solution is evaporated in a vacuum, the remainder is dissolved in water. It vid ain-I

jsyring av den vandige løsning med HC1 utfellende bunnfall ]I su: ges fra, vaskes med vann og tørkes i vakuum. Etter omkr'y<->;stallisasjon fra CHC13/CC14 får man 2,2-dimety1-4-(karboksy- jacidification of the aqueous solution with HC1 precipitating precipitate ]I: is suctioned off, washed with water and dried in vacuum. After recrystallization from CHC13/CC14, 2,2-dimethyl-4-(carboxy-

jmetoksy)-1,3-benzodioksolet som smelter ved 138-141°C.the imethoxy)-1,3-benzodioxole which melts at 138-141°C.

i in

i in

Natriumsaltet av denne forbindelse man man få f.eks. ved| omsetning av en metanolisk løsning av den frie syre med én j [ekvivalent natrium-metylat, inndampning av blandingen ogj i béhandling av resten med isopropyletér. Det smelter ved 256-! 2i! 60°C under spaltning. The sodium salt of this compound can be obtained e.g. by| reacting a methanolic solution of the free acid with one equivalent of sodium methylate, evaporating the mixture and treating the residue with isopropyl ether. It melts at 256-! 2 in! 60°C during decomposition.

Eksempel 19 En blanding av 4 g av den ifølge eksempel 18 erholdbare <ar~j boksylsyre, 8 g NaHC03 og 100 ml CC14 blandes etter tilset-! ning av et jodkrystall under røring ved -5°C med en løsning j av 4,5 g klor i 100 ml CC14. Man lar reagere ferdig ved 0°C ' og filtrerer deretter. Den erholdte felling ekstraheres mi ed \; CHC13, ekstraktet forenes med CCl4-fi,ltratet og inndampes i! vakuum. Inndampningsresten behandler man med CHC13/H20, ! j skiller fasene og inndamper CHCl3-fasen. Den krystallinske rest omkrystalliseres fra CC14, hvorved man får 2,2-dimetyl-4-(karboksymetoksy)-5,7-diklor-l,3-benzodioksol med smelte- I Example 19 A mixture of 4 g of the <ar~j carboxylic acid obtainable according to example 18, 8 g of NaHCO 3 and 100 ml of CC 4 is mixed after adding-! ning of an iodine crystal with stirring at -5°C with a solution j of 4.5 g chlorine in 100 ml CC14. The reaction is allowed to finish at 0°C and then filtered. The precipitate obtained is extracted mi ed \; CHC13, the extract is combined with the CCl4 filtrate and evaporated in! vacuum. The evaporation residue is treated with CHC13/H20, ! j separates the phases and evaporates the CHCl3 phase. The crystalline residue is recrystallized from CC14, whereby 2,2-dimethyl-4-(carboxymethoxy)-5,7-dichloro-1,3-benzodioxole is obtained with melt- I

punkt 143-145°C. point 143-145°C.

Eksempel 20Example 20

Produktet fra eksempel 19 er også tilgjengelig på følgende The product from Example 19 is also available at the following

måte: manner:

l l

I 2,2-dimetyl-4-hydroksy-5,7-diklor-l,3-benzodioksol omsettes' - ' I In 2,2-dimethyl-4-hydroxy-5,7-dichloro-1,3-benzodioxole react' - ' In

etter den i eksempel 17 beskrevne fremgangsmåte til 2,2jdi-j mety1-4-(karbeoksy-metoksy)-5,7-diklor-l,3-benzodioksol; som according to the method described in example 17 to 2,2-di-1-methyl-4-(carboxy-methoxy)-5,7-dichloro-1,3-benzodioxole; as

smelter ved 82 - 84°C. melts at 82 - 84°C.

i in

i in

j D! enne ester gir etter forsåping ifølge eksempel 18 den tIil<->! svarende frie syre, som oppviser det i eksempel 19 anførte jD! this ester gives after saponification according to example 18 the til<->! corresponding free acid, which shows what was stated in example 19

I i simeltepunkt. I in the melting point.

; Eksempel 21 ; Example 21

En blanding av 6,5 g av den ifølge eksempel 17 o<p>pnåelige ester, 8 g morfolin, 6 ml dimety1 formamid og 20 ml benzen A mixture of 6.5 g of the ester obtainable according to example 17, 8 g of morpholine, 6 ml of dimethylformamide and 20 ml of benzene

oppvarmes under tilbakeløpskjøling, inntil tynnsjiktskromatogram (sml. eksempel 18) ikke lenger viser noe utgangspro-j dukt. Den etter inndampning av løsningen erholdte rest oim-j krystalliseres fra isopropyletér, består av 2,2-dimetylr4-I- ,(morfolino-karbometoksy)-1, 3-benzodioksol og smelter ved i 9I2-9<3>°C. is heated under reflux until the thin-layer chromatogram (cf. example 18) no longer shows any starting product. The residue oim-j obtained after evaporation of the solution is crystallized from isopropyl ether, consists of 2,2-dimethylr4-1-(morpholino-carbomethoxy)-1, 3-benzodioxole and melts at i912-9<3>°C.

i i in i

i Eksempel 22 in Example 22

En løsning av 6,3 g 2 , 2-dimety 1-4-hydroksy-l, 3-benzodioksol' i 30 ml akrylnitril tilblandes 2 dråper av en 40%'ig metano- A solution of 6.3 g of 2,2-dimethyl 1-4-hydroxy-1,3-benzodioxole in 30 ml of acrylonitrile is mixed with 2 drops of a 40% methanol

mleiss k delørestntieng r auv ndbeer nrzyørltirng imettiyl latmimlbonakieumlø-hpy, drionknstyid l obg aroe ppsypoar r-ii<1><*>mleiss k delørestntieng r auv ndbeer nrzyørltirng imettiyl latmimlbonakiemlø-hpy, drionknstyid l obg aroe ppsypoar r-ii<1><*>

i av utgangsprodukt kan påvises på tynnsjikts-kromatogrammet \i(sml. eksempel 17). Inndampningsresten opptas i eddikester/ i of starting product can be detected on the thin-layer chromatogram \i (cf. example 17). The evaporation residue is taken up in vinegar/

; vann, blandingen filtreres, eddikester-fasen rystes ut med i ■ 1 n NaOH og ytterligere med vann og den med Na2S0^tørke' te '■' ; water, the mixture is filtered, the acetate phase is shaken out with i ■ 1 n NaOH and further with water and that with Na2S0^dry' tea '■'

! eddikesterløsning inndampes. ! acetic ester solution is evaporated.

i in

i in

I IN

i ben oljeaktige rest, 2,2-dimetyl-4-(2<1->cyanetoksy)-1,3-benzodioksol anvendes for den følgende omsetning med hydroksyl- in ben oily residue, 2,2-dimethyl-4-(2<1->cyanethoxy)-1,3-benzodioxole is used for the following reaction with hydroxyl-

amin. amine.

I i In i

Dertil tilsetter man under ytterkjøling med vann en løsning A solution is added to this during external cooling with water

i i in i

av 3,5 g hydroksylamin-hydroklorid i 15 ml metanol under of 3.5 g of hydroxylamine hydrochloride in 15 ml of methanol under

røring dråpevis 9 g av en 30%<1>ig metanolisk NaOCH^-løsningJ stirring dropwise 9 g of a 30%<1>ig methanolic NaOCH^ solutionJ

og suger av fra utfelt NaCl. Den slik erholdte løsning jtil-dryppes til en under tilbakeløp holdt og rørt løsning ajv and sucks off from precipitated NaCl. The solution obtained in this way is added dropwise to a solution kept under reflux and stirred adv

6,2 g 2,2-dimety1-4-(2'-cyanetoksy)-1,3-benzodioksol i 25 ' ml etanol. Etter Ytterligere 15 minutters tilbakeløp er i henhold til tynns j ikts-kromatogramet (sml. eksempel 1|7) alt omsatt.Den filtrerte løsning inndampes. Den oljeaktige 6.2 g of 2,2-dimethyl-4-(2'-cyanoethoxy)-1,3-benzodioxole in 25 ml of ethanol. After a further 15 minutes of reflux, according to the thin-layer chromatogram (cf. example 1|7) everything has been converted. The filtered solution is evaporated. The oily one

rest krystalliserer fra isopropanol består av 2,2-dimety 1-4;<->residue crystallizes from isopropanol consists of 2,2-dimethyl 1-4;<->

j(2 ' -karbamidoksim-etoksy)-1, 3-benzodioksol og smelter ved j(2 '-carbamidoxime-ethoxy)-1, 3-benzodioxole and melts at

100 - 103°C. 100 - 103°C.

" Eksempel 23 " Example 23

Løsningen av 10 g natriumsalt av 2 , 2-dimetyl-4-hydroksyf-5 , 7i- The solution of 10 g of the sodium salt of 2,2-dimethyl-4-hydroxyf-5,7i-

dibrom-1,3-benzodioksol og 0,7 g benzyltrietylammoniumklo- I i I rid i 40 ml kloracetonitri1 røres under tilbakeløpskjøling, inntil tynnsjikts-kromatogrammet (sml. eksempel ] viser Dibromo-1,3-benzodioxole and 0.7 g of benzyltriethylammonium chloride in 40 ml of chloroacetonitrile are stirred under reflux until the thin-layer chromatogram (cf. example ] shows

i fullstendig omsetning. Man inndamper i vakuum, tar restein opp i eddikester oa ryster ut med ln NaOH og deretter méd vann. Den etter inndampning av eddikesterløsningen tilbake-- blivende rest krystalliserer ved henstand i kjøleskap, bmkry-stallisert fra petroleter smelter det erholdte 2,2-dimety1-4- in full turnover. One evaporates in a vacuum, takes up the residue in vinegar or shakes it out with ln NaOH and then with water. The residue remaining after evaporation of the acetic ester solution crystallizes on standing in a refrigerator, bm crystallized from petroleum ether, the obtained 2,2-dimethyl1-4-

; : ci yanmetoksy-5,7-dibrom-l,3-benzodioksol ved 64-66 oC. !<!>; : ci yanmethoxy-5,7-dibromo-1,3-benzodioxole at 64-66 oC. !<!>

[ Eksempel 24[ Example 24

! En løsning av 2,2 g hydroksylamin-hydroklorid i 15 ml meta-j I hol blandes under røring ved 12°C dråpevis med 5,7 g av en j I 30%<1>ig metanolisk løsning av NaOCH^. Filtratet av den er- I ! A solution of 2.2 g of hydroxylamine hydrochloride in 15 ml of meta-j I hol is mixed with stirring at 12°C dropwise with 5.7 g of a j I 30%<1>ig methanolic solution of NaOCH^. The filtrate of it is- I

i I hi oldte blanding tildrypper man under røring til en under ' ji : tilbakeløp kokende løsning av 7,4 g 2,2-dimetyl-4-cyanmet- j i oksy-5,7-dibrom-l,3-benzodioksol i 25 ml etanol. Ca. 15j mi-' hi utter senere inndampes på rotasjonsfordamper. Man behan' d- i, ler resten med aceton og omkrystalliserer den oppståtte fel-i ling fra isopropanol. Det erholdte 2,2-dimety1-4-(karbamid-oksim-metoksy)-5,7-dibrom-l,3-benzodioksol smelter ved 153- In the above mixture, while stirring, a reflux boiling solution of 7.4 g of 2,2-dimethyl-4-cyanometh- ioxy-5,7-dibromo-1,3-benzodioxole is added dropwise in 25 ml ethanol. About. 15j mi-' hi otter is later evaporated on a rotary evaporator. The residue is treated with acetone and the resulting precipitate is recrystallized from isopropanol. The obtained 2,2-dimethyl-4-(urea-oxime-methoxy)-5,7-dibromo-1,3-benzodioxole melts at 153-

155°C. 155°C.

i in

i in

Eksempel 25 Example 25

I IN

I En løsning av 10 g 2 , 2-dimetyl-4-hydroksy-5,7-dijod-l,3pben- I A solution of 10 g of 2 , 2-dimethyl-4-hydroxy-5,7-diiodo-1,3pben-

zodioksol i 50 ml metanol blandes med 4,3 g av en 30%'ig zodioxol in 50 ml of methanol is mixed with 4.3 g of a 30%

metanolisk løsning av NaOCH-, og inndampes deretter i vakuum. methanolic solution of NaOCH-, and then evaporated in vacuo.

[ Resten opptas i 50 ml etanol og løsningen oppvarmes under i [ The residue is taken up in 50 ml of ethanol and the solution is heated under i

I tilbakeløp etter tilsetning av 2,65 g 3-klor-l, 2-propanJdiol, i 'inntil tynnsjikts-kromatogram (sml. eksempel 17) bare V1 jiserI jspor av utgangsprodukt. Den over Celite filtrerte løsning iinndampes i vakuum, resten tas opp i CHC1 /Ho0, CHCl-.-fase I 3 ^ J I jtørkes med Na2S04 og inndampes. Resten krystalliserer fra jisopropanol etter filtrering av den varme løsning med ak- In reflux after the addition of 2.65 g of 3-chloro-1,2-propanediol, in the thin-layer chromatogram (cf. Example 17) only traces of the starting product appear. The solution filtered over Celite is evaporated in vacuo, the residue is taken up in CHCl/Ho0, CHCl-.-phase I 3 ^ J I jdried with Na 2 SO 4 and evaporated. The residue crystallizes from isopropanol after filtering the hot solution with aq.

iptriovpt okksay rb)o-n5,. 7-Ddeit joodpp-slt,å3-tbtee nz2o,d2i-odkimseotl yslm-e4-lt(e2r 1,v3e'd -ep1o1k2-sy1-14°C. iptriovpt okksay rb)o-n5,. 7-Ddeit joodpp-slt,å3-tbtee nz2o,d2i-odkimseotl yslm-e4-lt(e2r 1,v3e'd -ep1o1k2-sy1-14°C.

I IN

i in

Eksempel 26 jNatriu msaltet av 5 g 2 , 2-dime tyl-4-hydroksy-5 , 7-dijod-l, 3-benzodioksol fremstilles i metanol ved tilsetning av 2,15 g av en 30%'ig metanolisk NaOCH^-løsning og inndampning av ! Example 26 The sodium salt of 5 g of 2,2-dimethyl-4-hydroxy-5,7-diiodo-1,3-benzodioxole is prepared in methanol by adding 2.15 g of a 30% methanolic NaOCH^ solution and evaporation of !

blandingen. Resten opptas etter tilsetning av 0,5 g trijetyl-benzylammoniumklorid i 30 ml epiklorhydrin og får henstå j over natten. Inndampningsresten behandles deretter med varm [eddikester og den filtrerte løsning inndampes. Man får såle- the mixture. The residue is taken up after the addition of 0.5 g of triethylbenzylammonium chloride in 30 ml of epichlorohydrin and allowed to stand overnight. The evaporation residue is then treated with hot vinegar and the filtered solution is evaporated. You get sole-

i jdoeds -15,,6 3-bg en2 z, o2d-idoimkesoty l 1-so4m -(g2 u1 l , 3 o'-ldjeih. ydPå roktysnyn-psrjoikpotkss-ykr)-om5 a, t7ipj--di-grammet (sml. eksempel 18) stiger det noe høyere enn uti- j i jdoeds -15,,6 3-bg en2 z, o2d-idoimkesoty l 1-so4m -(g2 u1 l , 3 o'-ldjeih. ydPå roktysnyn-psrjoikpotkss-ykr)-om5 a, t7ipj--di-grammet ( cf. example 18) it rises somewhat higher than uti- j

gangsproduktet og viser seg å være rent. Ved henstand kry- the gang product and turns out to be pure. In the event of respite,

stalliserer produktet og smelter derpå.ved 64-67°C. stagnates the product and then melts at 64-67°C.

i in

Eksempel 2 7Example 2 7

Til en løsning av 1,7 g 2,2-dimetyl-4-(karboksy-metoksy)-5,7-dijod-l,3-benzodioksol i 25 ml frisk destillert dimetyl-i formamid tildrypper man under røring 1 ml tiony lklorid J i DenI neste dag tilsetter man en 33%'ig løsning av metylamin ;i ! absolutt etanol inntil blandingen reagerer alkalisk og! i lar'denne star ytterligere over nattenLøsningen konsentreres To a solution of 1.7 g of 2,2-dimethyl-4-(carboxy-methoxy)-5,7-diiodo-1,3-benzodioxole in 25 ml of freshly distilled dimethyl-formamide, 1 ml of thionyl chloride is added dropwise while stirring J i On the next day, a 33% solution of methylamine is added; i ! absolute ethanol until the mixture reacts alkaline and! I let this stand further overnight. The solution is concentrated

i vakuum og felles deretter med mettet koksaltløsning. Det erholdte bunnfall omkrystalliseres fra etanol/vann. Det: ■ tørre 2,2-dimety1-4-(N-mety1-karbamy1-metoksy)-5,7-dijoid-in vacuum and then combine with saturated sodium chloride solution. The precipitate obtained is recrystallized from ethanol/water. It: ■ dry 2,2-dimethyl-4-(N-methyl-carbamyl-methoxy)-5,7-diioide-

1,3-benzodioksol smelter ved 146-148°C. 1,3-benzodioxole melts at 146-148°C.

Ei ksempel 28 Etter fremgangsmåten ifølge eksempel 23 får man fra nat' riumi-saltet av 2,2-dimety1-4-hydroksy-l,3-benzodioksol 2,2-di- ' mety1-4-cyanmetoksy-l,3-benzodioksol som oransjefarget olje. Example 28 Following the procedure according to example 23, 2,2-dimethyl-4-cyanomethoxy-1,3-benzodioxole is obtained from the sodium salt of 2,2-dimethyl-4-hydroxy-1,3-benzodioxole as orange colored oil.

: I : I

10 g av denne olje oppvarmes etter tilsetning av 0,1 g jsvo-vel i 20 ml etylendiamin 1 time til 100°C. Inndampningsjre-eddikestejr, den filtrerte løsning rystes ut flere ganger med vann og 10 g of this oil is heated after adding 0.1 g of sulfur in 20 ml of ethylenediamine for 1 hour to 100°C. Evaporation jre-acetic acid, the filtered solution is shaken out several times with water and

ekstraheres derpå med 2n HC1. Den sure vandige fase gjøjres alkalisk med NaOH-tilsetning og rystes ut med kloroform. then extracted with 2n HCl. The acidic aqueous phase is made alkaline with the addition of NaOH and shaken out with chloroform.

Etter inndampning av den med Na2S04 sicc. tørkete kloroform-jløsning får man et gullig pulver. Omkrystallisert fra i'so-' jpropanol danner det oppståtte 2,2-dimety1-4-( A 2 -imidaIzo- . ilin-2-yl-metoksy)-1, 3-benzodioksol fargeløse små bladerj som After evaporating it with Na2S04 sicc. dried chloroform solution gives a yellowish powder. Recrystallized from iso-propanol, the resulting 2,2-dimethyl-4-(A 2 -imidaIzo-.ilin-2-yl-methoxy)-1, 3-benzodioxole forms colorless small leaves which

jsmelter ved 158-161°C. melts at 158-161°C.

:Eksempe l 29:Example l 29

;5 g natriumsalt av 2,2 dimetyl-4-hydroksy-5 , 7-dibrom-l ,|3- | i benzodioksol røres etter tilsetning av 0,4 g benzyo ltri'etyl-■ammoniumklorid i 10 ml butylbromid 2 timer ved 100 C.Tnn-J |dampningsresten av reaksjonsblandingen tas deretter opp ! i eddikester, løsningen vaskes med ln NaOH og med vann og, i I iinndampes deretter. Den tilbakeblivende gullige olje bejstår 'av2 , 2-dimetyl-4-butoksy-5 , 7-dibrom-l, 3-benzodioksol, som | 2 3 ' ;5 g sodium salt of 2,2 dimethyl-4-hydroxy-5 , 7-dibromo-1 ,|3- | in benzodioxol is stirred after the addition of 0.4 g of benzoyltri'ethyl-■ammonium chloride in 10 ml of butyl bromide for 2 hours at 100 C.Tnn-J |the evaporation residue of the reaction mixture is then taken up ! in acetic acid, the solution is washed with ln NaOH and with water and, in I then evaporated. The remaining yellowish oil consists of 2,2-dimethyl-4-butoxy-5,7-dibromo-1,3-benzodioxole, which | 2 3'

har en brytningsindeks = 1, 5468 og på kiselgel 60 F. 254 has a refractive index = 1.5468 and on silica gel 60 F. 254

1 med løpemiddel: kloroform/metanol (9 : 1) oppviser en R1 f-!i 1 with eluent: chloroform/methanol (9:1) shows an R1 f-!i

verdi på 0,82. value of 0.82.

i in

Eksempel 30 Example 30

En løsning av 10 g av det ifølge eksempel 26 oppnåelige! 2,2-dimetyl-4-(2',3'-epoksy-propoksy)-5,7-dijod -1,3-benzodioksol i 50 ml etanol kokes med 2,2 g 2-amino-2-metyl-l, 3-pro-j pandiol under tilbakeløp inntil omsetningen i henhold til j A solution of 10 g of what can be obtained according to example 26! 2,2-dimethyl-4-(2',3'-epoxy-propoxy)-5,7-diiodo-1,3-benzodioxole in 50 ml of ethanol is boiled with 2.2 g of 2-amino-2-methyl-1 , 3-pro-j pandiol under reflux until the turnover according to j

.tynnsjikts-kromotagram (sml. eksempel ]8) er avsluttet.j Derpå tas inndampningsresten opp i eddikester, løsningen rystes først ut med vann og derpå med 2n HC1, hvorved eh ut- .thin-layer chromatogram (cf. example ]8) is finished.j Then the evaporation residue is taken up in vinegar, the solution is first shaken out with water and then with 2n HC1, whereby eh out-

i i fallende olje ved vanntilsetning igjen bringes i oppløsning. Den sure vandige løsning behandles med aktivt karbon, filtre- in the falling oil is again brought into solution by the addition of water. The acidic aqueous solution is treated with active carbon, filter-

res, gjøres alkalisk med NaOH og rystes ut med kloroform. ! Den med Na2S04 sicc. tørkete kloroformløsning etterlater<!>, j etter inndampningen en olje, som etter oppløsning i eddik- ' l ester og tilsetning av alkoholisk HCI gir et krystallinIsk res, made alkaline with NaOH and shaken out with chloroform. ! The one with Na2S04 sicc. dried chloroform solution leaves after evaporation an oil, which after dissolution in acetic ester and addition of alcoholic HCI gives a crystalline

i iprodukt. Dette smelter etter omkrystalliseringen fra iso1 - I<j>propanol eller acetonitril ved 205-208°C og består av hyi-jdrokloridet av 2,2-dimetyl-4-[31 -(a,a-di-hydroksymetyl-etyl-i|amino) -2 ' -hydroksy-propoksy ] -5 , 7-dijod-l, 3-benzodioksolJ. in iproduct. This melts after the recrystallization from iso1-1<j>propanol or acetonitrile at 205-208°C and consists of the hydrochloride of 2,2-dimethyl-4-[31-(a,a-dihydroxymethyl-ethyl-i |amino)-2'-hydroxy-propoxy]-5,7-diiodo-1,3-benzodioxole.

. Eksempel 31 . Example 31

;En løsning av 10 g 2,2 dimety1-4-hydroksy-l,3-benzodioksol _|ii 20 ml metanol tilsettes dråpevis under røring 10,83 g av en 30%'ig metanolisk NaOCH^-løsning og inndampes deretter.:Resten opptas i 15 ml kloracetaldehyd-dimetylacetal og blan-i di, ngen oppvarmes etter tilsetning av 1 g tetrabutylammonIi-lumbromid i flere dager under tilbakeløp inntil omsetningen Ifølge tynnsjikts-kromatogram (sjikt: kiselgel 60 F 254!, i j løpemiddel: cykloheksan/aceton =3:1) nesten er avslu!Ittet. A solution of 10 g of 2,2-dimethyl-4-hydroxy-1,3-benzodioxole in 20 ml of methanol is added dropwise with stirring to 10.83 g of a 30% methanolic NaOCH^ solution and then evaporated.: The residue is taken up in 15 ml of chloroacetaldehyde-dimethyl acetal and mixed, then heated after the addition of 1 g of tetrabutylammonium bromide for several days under reflux until the conversion According to thin-layer chromatogram (layer: silica gel 60 F 254!, i j eluant: cyclohexane/acetone =3:1) is almost complete!

Løsningen av inndampningsresten i eddikester vaskes medj fortynnet NaOH, tørkes sicc. over Na-jSO^, filtreres etter tilsetning av aktivt karbon og inndampes. Den slik erholdte The solution of the evaporation residue in acetic acid is washed with dilute NaOH, dried sicc. over Na-jSO^, filtered after addition of active carbon and evaporated. The thus obtained

olje destilleres (kokepunkt 155-157°C/12 torr) og består| av 2, 2-dimety1-4(21,21-dimetoksy-etoksy)-1,3-benzodioksol.| På oil is distilled (boiling point 155-157°C/12 torr) and consists| of 2, 2-dimethyl-4(21,21-dimethoxy-ethoxy)-1,3-benzodioxole.| On

1 tynns jikts-kromatogram (s.o.) viser den en Rf-verdi på 0,44, 1 thin's liquid chromatogram (s.o.) shows an Rf value of 0.44,

utgangsproduktet en verdi på 0,30. Brytningsindeksen for the output product a value of 0.30. The refractive index of

24 24

det erholdte dimetylacetal: nD = 1,4971. the dimethyl acetal obtained: nD = 1.4971.

1 Eksempel 32. I 1 Example 32. I

Innføres 7,6 g 2-amino-2-metyl-l,3-propandiol (serinol) i stedet j for 2-amino-2-metyl-l,3-propandion i henhold til eksempel 30 får man ved en eller lik fremgangsmåte hydrokloridet aVj 2,2-dimety1-4-[31 -(1",3"-dihydroksyisopropylamino)-2'-hydroksy-propoksy ]-5 , 7-dijod-l, 3-benzodioksol, som omkrystalliseres If 7.6 g of 2-amino-2-methyl-1,3-propanediol (serinol) is introduced instead of 2-amino-2-methyl-1,3-propanedione according to example 30, one or a similar method yields the hydrochloride aVj 2,2-dimethyl-4-[31-(1,3"-dihydroxyisopropylamino)-2'-hydroxy-propoxy]-5,7-diiodo-1,3-benzodioxole, which is recrystallized

ifra acetonitril/metanol og smelter ved 190 195°C. from acetonitrile/methanol and melts at 190 195°C.

1 Eksempel 33 1 Example 33

En suspensjon av 10 g av det ifølge eksempel 18 oppnåelige 2,2-dimetyl-4-(karboksy-metoksy)-1,3-benzodioksol i 150' A suspension of 10 g of the 2,2-dimethyl-4-(carboxy-methoxy)-1,3-benzodioxole obtainable according to example 18 in 150'

ml CH2C12tilblandes under omrøring 3,3 g acetonoksim og derpå tildryppes en løsning av 9,2 g N,N-dicykloheksy1-kar-i i bodiimid i 80 ml CH_C10. Etter 30 minutter er omsetningen i henhold tii tynnsjjikts-kromatogram (sjikt: kiselgel—60—1I I jF 254, løpemiddel: cykloheksan/aceton = 1:1) avsluttet, ml of CH2C12 is mixed with stirring with 3.3 g of acetone oxime and then a solution of 9.2 g of N,N-dicyclohexy1-car-i in bodiimide in 80 ml of CH_C10 is added dropwise. After 30 minutes, the reaction is complete according to the thin-layer chromatogram (layer: silica gel—60—1I I jF 254, eluant: cyclohexane/acetone = 1:1)

jlnndampningsresten tas opp i isopropyletér, fellingen som j|er falt ut over natten suges fra og filtratet inndampes. Den krystallinske rest omkrystalliseres fra isopropyletér. pet The evaporation residue is taken up in isopropyl ether, the precipitate that has fallen out overnight is sucked off and the filtrate is evaporated. The crystalline residue is recrystallized from isopropyl ether. pet

.slik erholdte aceton-O- (2 , 2-dimetyl-l, 3-benzodioksol-4-oksyj- .thus obtained acetone-O-(2,2-dimethyl-1,3-benzodioxole-4-oxyj-

<i>acetyl)-oksim smelter ved 73 - 75°C.<i>acetyl)-oxime melts at 73 - 75°C.

.De i det følgende angitte nye pyrogallol-etere med den .'generelle formel The following new pyrogallol ethers with the general formula

i in

jble erholdt som beskrevet i eksemplene 17 til 33: was obtained as described in Examples 17 to 33:

I IN

Claims (9)

L. Nye pyrogallolderivater med den generelle formel L. New pyrogallol derivatives of the general formula hvor R1 ogR2 kan være like eller forskjellige og betyr hydrogen eller lavere alkyl, og R erwhere R1 and R2 may be the same or different and mean hydrogen or lower alkyl, and R is (i) hydrogen eller i (jii) i i i i (i) hydrogen or i (jii) i i i i hvorunder (;i) når R betyr hydrogen betyr X, Y og Z hydrogen, halogen eller nitro med det forbehold at ikke alle tre samtidig j er hydrogen, og med det videre forbehold at når Rj_, R2, X og Z betyr hydrogen kan ikke Y være noen N02-grupp|e; i og (■ii) a) nå R betyr gruppen under which (;i) when R means hydrogen, X, Y and Z means hydrogen, halogen or nitro with the proviso that not all three at the same time j are hydrogen, and with the further proviso that when Rj_, R2, X and Z mean hydrogen, Y cannot be any N02 groups; in and (■ii) a) now R means the group er R^ og R^ like eller forskjellige og betyr hydrogen eller laverI e !i alkyl, X, Y og Z er likeledes like eller forskjellige og betyr hydrogen, halogen eller nitro, n står for null, 1 eller 2, R,- hydrogen, oksiranyl, mono- eller dihydroksyalkyl, N- (dihydroksyalkyl) -amino-hydro'ksy4 alkyl, karboksy, karbalkoksy, karbam2 yl, N-alkylk'ar-bamyl, N , N-dia 1 kyl karbamyl, cyan, A -imidazolin-;I2-yl, amidoksimester eller dialkylacetal, hvorunder amin-resten til karbamylgruppen også kan være en mettiet i heterocyklisk ring med tilsammen to heterogenatomer; eller b) X er hydrogen eller-allyl, Y, Z, R^ og R4 er-hyd-rogen-Jog—' n ler null, betyr gruppen are R^ and R^ equal or different and means hydrogen or lower alkyl, X, Y and Z are likewise the same or different and mean hydrogen, halogen or nitro, n stands for zero, 1 or 2, R,- hydrogen, oxiranyl, mono- or dihydroxyalkyl , N-(dihydroxyalkyl)-amino-hydroxy4 alkyl, carboxy, carbaloxy, carbam2 yl, N-alkylcarbamyl, N , N-dia 1 alkyl carbamyl, cyan, A -imidazolin-;12-yl, amidoxy ester or dialkyl acetal, wherein the amine residue of the carbamyl group may also be a metiate in heterocyclic ring with a total of two heteroatoms; or b) X is hydrogen or -allyl, Y, Z, R^ and R4 are-hydrogen-Jog—' n is zero, means the group hvori Rg kajn jvære hydrogen eller lavere alkyl el] er sammen med R-, danner en fem- eller seksleddet heterocyklisk ring, som maksimalft i ! in which Rg kajn jbe hydrogen or lower alkyl or] is together with R-, forms a five- or six-membered heterocyclic ring, which maximally i ! 7 I inynI nle, hoalldkoer ksytao lkhyetle, rocgyeknlaoatolmkyerl, , dR^ i'ablekytylar mainlokayllk, yall, kaenryyll, , <a> ar <l> a <ki> lk <-> yl, ! heIterogenalkyl, karbamoylalkyl eller en fem- eller seksleddet og likeledes kondensert heterocyklisk rest med maksimalt tre heterogenatomer, samt deres salter med uorganiske eller organiske syrer eller baser. i i ! I p.j Forbindelse ifølge krav 1, karakterisert y ; |ie d at den er 2,2-dimetyl-4-(2'-hydroksy-3'-tert.butyl-lamiinopropoksy)-1,3-benzodioksol henholdsvis dets salt med en farmasøytisk akseptabel syre, fortrinnsvis hydrokloridet. i ;3 .j iAnvendelse av nye kjernesubstituerte pyrogallolderivater med den generelle formel 7 I inynI nle, hoalldkoer ksytao lkhyetle, rocgyeknlaoatolmkyerl, , dR^ i'ablekytylar mainlokayllk, yall, kaenryyll, , <a> ar <l> a <ki> lk <-> yl, ! Heterogeneous alkyl, carbamoylalkyl or a five- or six-membered and similarly condensed heterocyclic radical with a maximum of three heteroatoms, as well as their salts with inorganic or organic acids or bases. in i ! IN p.j Compound according to claim 1, characterized y ; |ie d that it is 2,2-dimethyl-4-(2'-hydroxy-3'-tert.butyl-laminopropoxy)-1,3-benzodioxole or its salt with a pharmaceutically acceptable acid, preferably the hydrochloride. in ;3 .j iUse of new nucleus-substituted pyrogallol derivatives with the general formula hvor R., R„, X, Y og Z har den i krav 1 under (i) angitte 1 2 .. i betydning samt deres salter med baser som agrokjemikalierj eller som råstoffer ved fremstilling a^ v slike. 4.' Anvendelse av nye kjernesubstituerte pyrogallolderivater i med den i krav 3 angitte generelle formel (I a), hvori ! R^ , R,,, X, Y og Z har den der angitte betydning, samt der-es j salter med baser som råstoffer ved fremstilling av legemidler, i røntgenkontrastmidler eller fotosensibilisatorer. i ! 5' ., ! Anvendelse av nye kj ernesubstituerte pyrogallolderivater med den generelle formel hvj or R^ , R^' x' Rg°9 R7 nar den i krav 1 under (ii) b) angitte betydning, eventuelt i form av optisk aktive isomere som p -blokkere og analgetika. I I 6.1 Anvendelse av nye kj ernesubstituerte pyrogallolderivater med den i krav 5 angitte formel (Ib) i form av salter med ionebyttere som ^-blokkere og analgetika. i i7.| Fremgangsmåte ved fremstilling av nye pyrogallolderivajter med den generelle formel (Ia) , karakterisert ] y je d at man behandler et 4-hydroksy-1, 3-benzodioksol iried den generelle formel where R., R„, X, Y and Z have that in claim 1 under (i) indicated 1 2 .. in meaning as well as their salts with bases as agrochemicalsj or as raw materials in the manufacture of a^ v such. 4.' Use of new core-substituted pyrogallol derivatives with the general formula (I a) specified in claim 3, wherein ! R^ , R,,, X, Y and Z have the meaning indicated there, as well as there-es j salts with bases as raw materials in the manufacture of medicines, in X-ray contrast agents or photosensitizers. in ! 5' ., ! Use of new core-substituted pyrogallol derivatives with the general formula where R^ , R^' x' Rg°9 R7 when the meaning stated in claim 1 under (ii) b), possibly in the form of optically active isomers such as p-blockers and analgesics. I I 6.1 Use of new core-substituted pyrogallol derivatives with the formula (Ib) stated in claim 5 in the form of salts with ion exchangers as β-blockers and analgesics. in i7.| Process for the production of new pyrogallol derivatives with the general formula (Ia), characterized by treating a 4-hydroxy-1, 3-benzodioxole iride the general formula I hyor R, og R har den i krav 1 angitte betydning, fortrinnsvis ' ! i betydning, j i i ,et inert løsningsmiddel eller løsningsmiddelblanding, i en-j eller totrinnsreaksjon, eventuelt under anvendelse av syr,e- j bindende tilsetninger og/eller katalysatorer, med halogener-j Ings- og /eller nitreringsmidler.In hyor R, and R has the meaning stated in claim 1, preferably ' ! in meaning, j i i , an inert solvent or solvent mixture, in a one-j or two-stage reaction, optionally using acid,e-j binding additives and/or catalysts, with halogen-j Ings and/or nitrating agents. 8.]F remgangsmåte ved fremstilling av nye pyrogalloletere med j den generelle formel 8.]Procedure for the production of new pyrogallole ethers with the general formula I <1> ihyor X, R^ , R , R- og R7 har den i krav 1 under (ii) b) 'angitte betydning, samt deres salter og optisk aktive isomere, i ikijarakterisert ved at man omsetter et 4- hydroksy-1,3-benzodioksol med den generelle formel i I In <1> ihyor X, R^ , R , R- and R7 have the meaning given in claim 1 under (ii) b) 'as well as their salts and optically active isomers, in iki characterized by converting a 4- hydroxy-1,3-benzodioxole of the general formula in I i hvori R-^ , R^ og X har den ovenfor angitte betydning, eller et alkalisalt herav med et epihalogenhydrin, behandler det derved erholdte produkt med den generelle formel in which R-^ , R^ and X have the meaning given above, or an alkali salt thereof with an epihalohydrin, it treats thereby obtained product with the general formula i .stiller et halogenatom, med et amin med den generelle for1 mell1 i i l i represents a halogen atom, with an amine of the general formula i i l i hvori R,, og R-, har den ovenfor angitte betydning, og om ønsket spalter det derved erholdte derivat med den generelle formell i(Ib) med hensyn til de optiske antipoder og/eller eventuelt | med en fysiologisk fordragelig syre eller base overfører i et salt. i in which R,, and R-, have the meaning indicated above, and if desired, the derivative thus obtained cleaves with the general formula i(Ib) with respect to the optical antipodes and/or optionally | with a physiologically tolerable acid or base transfers in a salt. in 9. Fremgangsmåte ifølge krav 8, karakterisert v e d at man som fysiologisk fordragelig syre for salt-j dannelse anvender en ionebytter. <:> i |l0. Fremgangsmåte ved fremstilling av nye derivater av pyrogalloletere med den generelle formel 9. Method according to claim 8, characterized in that an ion exchanger is used as a physiologically tolerable acid for salt formation. <:> i |l0. Procedure for the preparation of new derivatives of pyrogallo ethers with the general formula hvor R1# R2 , R3 , R4 , R5 , X, Y, Z og n har den i krav 1 linder (ii) a) angitte betydning, karakterisert ved at man omsetter et pyrogallolderivat med den gene- I relle formel i i i i i i where R1# R2 , R3 , R4 , R5 , X, Y, Z and n have the meaning specified in claim 1 linder (ii) a) characterized by reacting a pyrogallol derivative with the gene- I real formula i i i i in in hvor R^ , R2 , X, Y og Z har den ovenfor angitte betydning, eller et fenolat herav, fortrinnsvis i et inert løsnings- I middel eller løsningsmiddelblandinger, med en forbindelse med den generelle formel i where R , R 2 , X, Y and Z have the above meaning, or a phenolate thereof, preferably in an inert solution In agent or solvent mixtures, with a compound of the general formula in bhveotyr dRni^n, g R^ som og Rn ,- healr leor vbenentyevr ntee n CbHet.CydNn-ginrgup, pRe ^o' g dA en hasalmomgeein, heyn drsouglefnon, yn lo= ksynurelsl t og elR ler ' ei n dCeHt .CtNi-lgfreulplpeet , abt eRty^ r og en Rd4 ober beltpj binding med det nabostående karbonatom, eventuelt i et I i iI erholdt derivat med den generelle formel (Ic). overføre en | gruppe R5 i en annen gruppe R^ , og i det tilfellet at xjog/ eller Y og/eller Z betyr hydrogen, behandle den erholdte forbindelse med den generelle formel (Ic) om ønsket med h <i> alogenerings- og/eller nitreringsmidler. I IP vro <q> allolderivat er med den generelle formel (I) bhveotyr dRni^n, g R^ as and Rn ,- healr leor vbenentyevr ntee n CbHet.CydNn-ginrgup, pRe ^o' g dA en hasalmomgeein, heyn drsouglefnon, yn lo= ksynurelsl t and elR ler ' ei n dCeHt .CtNi -lgfreulplpeet , abt eRty^ r and a Rd4 ober beltpj bond with the neighboring carbon atom, optionally in a I in iI derivative obtained with the general formula (Ic). transfer a | group R5 in another group R^ , and in the case that xjog/ or Y and/or Z is hydrogen, treat the obtained compound of the general formula (Ic) if desired with h<i> halogenating and/or nitrating agents. IN IP vro <q> allol derivative is of the general formula (I) hvor R, og R2 uavhengig er hydrogen eller lavere alkyl, og Rwhere R, and R2 are independently hydrogen or lower alkyl, and R (i) hydrogen eller (i) hydrogen or idet I(i) når R betyr hydrogen er X, Y og Z hydrogen, halogen eller nit--j ro men ikke alle samtidig hydrogen, og de ikke er NCX, når R-^, R2 , X og Z er hydrogen; ogwhile I(i) when R is hydrogen, X, Y and Z are hydrogen, halogen or nitrogen but not all together hydrogen, and they are not NCX, when R-^, R 2 , X and Z are hydrogen; and (ii) A) når R er gruppen (ii) A) when R is the group er R, og R, uavhengig hydro gen eller lavere alkyl, X, Y og Z uavhengig hydrogen, halogen eller NC>2 , n 0, 1 eller 2, R^ hydrogen, oksiranyl, mono- eller dihydroksyalkyl, N-(dihydroksyalkyl)-amino-hydroksyalkyl, karboksy, karbalkoksy, karbamyl, N-alkylkarbamyl, N,N-dialkylkarbamyl, cyan,A 2-imidazolin-2-yl, amidoksim, oksimestere eller dialkylace--tal, idet karbamylgruppens aminrest også kan være en mettet heterocyklisk ring med totalt to heterogenatomer; eller b) X er hydrogen eller allyl, Y, Z, R, og R- er hydrogen og n er null, R;- betyr is R, and R, independently hydro gen or lower alkyl, X, Y and Z independently hydrogen, halogen or NC>2 , n 0, 1 or 2, R^ hydrogen, oxiranyl, mono- or dihydroxyalkyl, N-(dihydroxyalkyl)-amino-hydroxyalkyl, carboxy, caralkyloxy . or b) X is hydrogen or allyl, Y, Z, R, and R- are hydrogen and n is zero, R;- means hvor Rg er hydrogen eller lavere i I alkyl eller sammen med R, danner en 5- eller 6-leddet mettetI heterocyklisk ring med maks. 2 heterogenatomer, R^ en hydrokarbonr i rest, alkoksyalkyl, dialkylaminoalkyl, heteroalkyl, karbamoylalkyl i eller fem- eller 6-leddet og evt. kondensert heterocyklisk rest I med maks. 3 heterogenatomer, I samt deres salter med syrer eller baser. i Fremstilling av forbindelsene er beskrevet. Forbindelsene er anvendelige som agrokjemikalier eller som råstoffer for fremstilling av disse på den ene side og som råstoffer for fremstilling av legemidler, røntgenkontrastmidler eller fotosensibilisa-tor på den annen side. Noen forbindelser med formel (I) i form av salter med ionebyttere er verdifulle ji -blokkere og analgetika. i iwhere Rg is hydrogen or lower in I alkyl or together with R, forms a 5- or 6-membered saturated I heterocyclic ring with max. 2 heteroatoms, R^ a hydrocarbon residue, alkoxyalkyl, dialkylaminoalkyl, heteroalkyl, carbamoylalkyl i or five- or six-membered and optionally condensed heterocyclic residue I with max. 3 heteroatoms, I as well as their salts with acids or bases. in Preparation of the compounds is described. The compounds are usable as agrochemicals or as raw materials for the production of these on the one hand and as raw materials for the production of pharmaceuticals, X-ray contrast agents or photosensitizers on the other hand. Some compounds of formula (I) in the form of salts with ion exchangers are valuable ji -blockers and analgesics. in i
NO831680A 1982-05-13 1983-05-11 PYROGALL-DERIVATIVES. NO831680L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AT188882A AT375654B (en) 1982-05-13 1982-05-13 METHOD FOR PRODUCING NEW PYROGALLOL [THERS AND THEIR SALTS
AT467182A AT375360B (en) 1982-12-23 1982-12-23 METHOD FOR PRODUCING NEW 1,3-BENZODIOXOL DERIVATIVES AND THEIR SALTS
AT129883A AT378191B (en) 1983-04-12 1983-04-12 METHOD FOR PRODUCING NEW PYROGALLOLAETHER DERIVATIVES

Publications (1)

Publication Number Publication Date
NO831680L true NO831680L (en) 1983-11-14

Family

ID=27147336

Family Applications (1)

Application Number Title Priority Date Filing Date
NO831680A NO831680L (en) 1982-05-13 1983-05-11 PYROGALL-DERIVATIVES.

Country Status (6)

Country Link
EP (1) EP0095454A3 (en)
JP (1) JPS58206581A (en)
AU (1) AU566107B2 (en)
CA (1) CA1233181A (en)
DK (1) DK210483A (en)
NO (1) NO831680L (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4472427A (en) * 1980-12-23 1984-09-18 Merck & Co., Inc. (Aralkylamino-2-OR-propoxy)heterocyclic compounds
US5541204A (en) * 1994-12-02 1996-07-30 Bristol-Myers Squibb Company Aryloxypropanolamine β 3 adrenergic agonists
US6818660B2 (en) 1996-04-09 2004-11-16 Nps Pharmaceuticals, Inc. Calcilytic compounds
AU726659B2 (en) * 1996-04-09 2000-11-16 Nps Pharmaceuticals, Inc. Calcilytic compounds
TW483881B (en) 1996-12-03 2002-04-21 Nps Pharma Inc Calcilytic compounds
US7202261B2 (en) 1996-12-03 2007-04-10 Nps Pharmaceuticals, Inc. Calcilytic compounds
IT1304513B1 (en) * 1998-12-30 2001-03-19 Endura Spa PROCESS FOR THE SYNTHESIS OF 5- (ALPHA-HYDROXIALKYL) BENZO (1,3) DIOXINS.
SE9902987D0 (en) 1999-08-24 1999-08-24 Astra Pharma Prod Novel compounds
FR2798126B1 (en) * 1999-09-08 2001-10-19 Sanofi Synthelabo HETEROARYLOXYPROPANOLAMINES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2802533B1 (en) * 1999-12-17 2002-02-15 Sanofi Synthelabo PHENOXYPROPANOLAMINES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2802529B1 (en) * 1999-12-17 2004-07-30 Sanofi Synthelabo PHENOXYPROPANOLAMINES, PROCESS FOR PREPARING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
FR2802531B1 (en) * 1999-12-17 2002-02-15 Sanofi Synthelabo PHENOXYPROPANOLAMINES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
WO2001043744A1 (en) * 1999-12-17 2001-06-21 Sanofi-Synthelabo Phenoxypropanolamines, method for producing them and pharmaceutical compositions containing them
CO5300399A1 (en) 2000-02-25 2003-07-31 Astrazeneca Ab HETEROCICLIOCS CONTAINING NITROGEN, PROCESS FOR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
AR028948A1 (en) 2000-06-20 2003-05-28 Astrazeneca Ab NEW COMPOUNDS
US7005439B2 (en) 2000-06-20 2006-02-28 Astrazeneca Ab Compounds
GB0104050D0 (en) 2001-02-19 2001-04-04 Astrazeneca Ab Chemical compounds
AR035230A1 (en) 2001-03-19 2004-05-05 Astrazeneca Ab BENCIMIDAZOL COMPOUNDS, PROCESS FOR PREPARATION, PHARMACEUTICAL COMPOSITION, PROCESS FOR THE PREPARATION OF SUCH PHARMACEUTICAL COMPOSITION, AND USES OF THESE COMPOUNDS FOR THE PREPARATION OF MEDICINES
GB0107228D0 (en) 2001-03-22 2001-05-16 Astrazeneca Ab Chemical compounds
SE0101038D0 (en) 2001-03-23 2001-03-23 Astrazeneca Ab Novel compounds
SE0103818D0 (en) 2001-11-15 2001-11-15 Astrazeneca Ab Chemical compounds
SE0301369D0 (en) 2003-05-09 2003-05-09 Astrazeneca Ab Chemical compounds
TW200738634A (en) 2005-08-02 2007-10-16 Astrazeneca Ab New salt

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3726924A (en) * 1971-03-26 1973-04-10 Hoffmann La Roche Method for the preparation of tris (dimethylamino) methane
USRE27822E (en) * 1971-07-06 1973-11-27 Substituted phenoxy-z-hydroxy- j-isopropylamino-propanes
DE2816474A1 (en) * 1978-04-15 1979-10-25 Bayer Ag DICHLORBENZODIOXOL DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS SYNERGIS IN INSECTICIDES AND ACARICIDES

Also Published As

Publication number Publication date
AU566107B2 (en) 1987-10-08
EP0095454A2 (en) 1983-11-30
CA1233181A (en) 1988-02-23
EP0095454A3 (en) 1985-04-03
JPS58206581A (en) 1983-12-01
AU1440983A (en) 1983-11-17
DK210483D0 (en) 1983-05-11
DK210483A (en) 1983-11-14

Similar Documents

Publication Publication Date Title
NO831680L (en) PYROGALL-DERIVATIVES.
DK172076B1 (en) Derivatives of 4-benzyl-1- (2H) -phthalazinone, process for the preparation thereof, the compounds for therapeutic use, the use of the compounds for the preparation of drugs, drugs containing the compounds and the method for the preparation of such drugs
SU820659A3 (en) Method of preparing 4-amino-5-alkylsulfonyl-o-anisamide derivatives,their salts,oxides,left-and right-rotational isomers (their variations)
DE69200378T2 (en) Indole derivatives, processes for their preparation and medicaments containing them.
EP0417210A1 (en) Novel o-(3-amino-2-hydroxypropyl)-hydroximic acid halides and process for preparing the same.
CN103232467B (en) A kind of Sinomenine structure-modified compound and preparation method thereof
EP0124476A1 (en) Carboxamides, process for their preparation and pharmaceutical preparations containing them
KR20200011943A (en) Crystallization of Heterocyclidene Acetamide Derivatives
NO128653B (en)
EP0071935B1 (en) 1-phenyl-2-aminocarbonylindole compounds, process and intermediates for their preparation and medicines containing them
EP0089028A1 (en) Theophyllin derivatives, and process for their preparation
CN103539659B (en) 2,4-benzoic acid dibenzyl derivative and preparation method thereof and application
NO158739B (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 2-PIPERAZINOPYRIMIDINE DERIVATIVES.
DE3813531A1 (en) Novel 2-aminoalkyl-4-benzyl-1-(2H)-phthalazinone derivatives
JPS5973579A (en) Benzofuran or benzothiophene derivative, diuretic agent containing said compound as active constituent and preparation thereof
NO118676B (en)
DK158944B (en) METHOD OF ANALOGUE FOR PREPARING SUBSTITUTED METHYLIMIDAZOLE COMPOUNDS
CA1146575A (en) Process for the manufacture of novel derivatives of 2- aminoethanol
US4973691A (en) Etheric derivative of 4(3H)-quinazolinone and a process for preparation thereof
DD145747A5 (en) PREPARATION OF HYDROXYESEDSAFE DERIVATIVES
US20130274270A1 (en) Polymorphs of 3-chloro-4[(2r)-2-(4-chlorophenyl)-4-[(1r)-1-(4-cyanophenyl)ethyl]-1-piperazinyl]-benzonitrile, pharmaceutical compositions and method of use comprising said polymorphs, and a process for preparing them
EP0006458B1 (en) N1-benzoyl-n2-phenyl-1,3-diaminopropane-2-ols and their salts, process for their preparation and medicaments containing them
NO150553B (en) INFLATABLE BATH
DE69016378T2 (en) Substituted benzothiazolinones, their preparation and pharmaceutical compositions containing them.
JPH03188060A (en) Benzylselenobenzamides obtained erom anilines and benzylamines and its preparation